<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnmol.2024.1376681</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Perinatal exposure to atazanavir-based antiretroviral regimens in a mouse model leads to differential long-term motor and cognitive deficits dependent on the NRTI backbone</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Dhume</surname> <given-names>Shreya H.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn0003"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2154489/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Balogun</surname> <given-names>Kayode</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn0003"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2663080/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Sarkar</surname> <given-names>Ambalika</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/408501/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Acosta</surname> <given-names>Sebastian</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Mount</surname> <given-names>Howard T. J.</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2664183/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Cahill</surname> <given-names>Lindsay S.</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1577536/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Sled</surname> <given-names>John G.</given-names></name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/115724/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Serghides</surname> <given-names>Lena</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff8"><sup>8</sup></xref>
<xref ref-type="aff" rid="aff9"><sup>9</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/41311/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Toronto General Hospital Research Institute, University Health Network</institution>, <addr-line>Toronto, ON</addr-line>, <country>Canada</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Pathology, Montefiore Medical Center and Albert Einstein College of Medicine</institution>, <addr-line>Bronx, NY</addr-line>, <country>United States</country></aff>
<aff id="aff3"><sup>3</sup><institution>Institute of Medical Sciences, University of Toronto</institution>, <addr-line>Toronto, ON</addr-line>, <country>Canada</country></aff>
<aff id="aff4"><sup>4</sup><institution>Tanz Centre for Research in Neurodegenerative Diseases, Department of Psychiatry and Physiology, University of Toronto</institution>, <addr-line>Toronto, ON</addr-line>, <country>Canada</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Chemistry, Memorial University of Newfoundland</institution>, <addr-line>St. John&#x2019;s, NL</addr-line>, <country>Canada</country></aff>
<aff id="aff6"><sup>6</sup><institution>Mouse Imaging Centre, Toronto Centre for Phenogenomics</institution>, <addr-line>Toronto, ON</addr-line>, <country>Canada</country></aff>
<aff id="aff7"><sup>7</sup><institution>Department of Medical Biophysics, University of Toronto</institution>, <addr-line>Toronto, ON</addr-line>, <country>Canada</country></aff>
<aff id="aff8"><sup>8</sup><institution>Women&#x2019;s College Research Institute</institution>, <addr-line>Toronto, ON</addr-line>, <country>Canada</country></aff>
<aff id="aff9"><sup>9</sup><institution>Department of Immunology, University of Toronto</institution>, <addr-line>Toronto, ON</addr-line>, <country>Canada</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0004"><p>Edited by: Isabella Zanella, University of Brescia, Italy</p></fn>
<fn fn-type="edited-by" id="fn0005"><p>Reviewed by: Robert Cabrera, Baylor College of Medicine, United States</p>
<p>Natalie A Prowse, Carleton University, Canada</p></fn>
<corresp id="c001">&#x002A;Correspondence: Lena Serghides, <email>lena.serghides@utoronto.ca</email></corresp>
<fn fn-type="equal" id="fn0003"><p><sup>&#x2020;</sup>These authors have contributed equally to this work and share first authorship</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>04</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>17</volume>
<elocation-id>1376681</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>01</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>03</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Dhume, Balogun, Sarkar, Acosta, Mount, Cahill, Sled and Serghides.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Dhume, Balogun, Sarkar, Acosta, Mount, Cahill, Sled and Serghides</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec id="sec1">
<title>Background</title>
<p>Combination antiretroviral therapy (ART) use in pregnancy has been pivotal in improving maternal health and reducing perinatal HIV transmission. However, children born HIV-exposed uninfected fall behind their unexposed peers in several areas including neurodevelopment. The contribution of <italic>in utero</italic> ART exposure to these deficits is not clear. Here we present our findings of neurocognitive outcomes in adult mice exposed <italic>in utero</italic> to ART.</p>
</sec>
<sec id="sec2">
<title>Methods</title>
<p>Dams were treated with a combination of ritonavir-boosted atazanavir with either abacavir plus lamivudine (ABC/3TC&#x2009;+&#x2009;ATV/r) or tenofovir disoproxil fumarate plus emtricitabine (TDF/FTC&#x2009;+&#x2009;ATV/r), or water as a control, administered daily from day of plug detection to birth. Offspring underwent a battery of behavioral tests that investigated motor performance and cognition starting at 6-weeks of age and ending at 8&#x2009;months. Changes in brain structure were assessed using magnetic resonance imaging and immunohistochemistry. Expression of genes involved in neural circuitry and synaptic transmission were assessed in the hippocampus, a region strongly associated with memory formation, using qPCR.</p>
</sec>
<sec id="sec3">
<title>Findings</title>
<p>Pups exposed to TDF/FTC&#x2009;+&#x2009;ATV/r showed increased motor activity and exploratory drive, and deficits in hippocampal-dependent working memory and social interaction, while pups exposed to ABC/3TC&#x2009;+&#x2009;ATV/r showed increased grooming, and deficits in working memory and social interaction. Significant volumetric reductions in the brain were seen only in the ABC/3TC&#x2009;+&#x2009;ATV/r group and were associated with reduced neuronal counts in the hippocampus. Altered neurotransmitter receptor mRNA expression as well as changes in expression of the neurotrophic factor BDNF and its receptors were observed in both ART-exposed groups in a sex-dependent manner.</p>
</sec>
<sec id="sec4">
<title>Interpretation</title>
<p>In our model, <italic>in utero</italic> ART exposure had long-term effects on brain development and cognitive and motor outcomes in adulthood. Our data show that neurological outcomes can be influenced by the type of nucleoside reverse transcriptase inhibitor backbone of the regimen and not just the base drug, and display sex differences.</p>
</sec>
</abstract>
<kwd-group>
<kwd>HIV antiretrovirals</kwd>
<kwd>protease inhibitors</kwd>
<kwd>neurodevelopment</kwd>
<kwd>cognition</kwd>
<kwd>HEU</kwd>
<kwd>hyperactivity</kwd>
<kwd>memory</kwd>
<kwd>MRI</kwd>
</kwd-group>
<contract-sponsor id="cn1">Canadian Institutes of Health Research<named-content content-type="fundref-id">10.13039/501100000024</named-content></contract-sponsor>
<contract-sponsor id="cn2">Canada Research Chair</contract-sponsor>
<counts>
<fig-count count="6"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="134"/>
<page-count count="17"/>
<word-count count="13549"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Brain Disease Mechanisms</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec5">
<label>1</label>
<title>Introduction</title>
<p>The introduction of antiretroviral (ARV) therapy (ART) for the prevention of perinatal HIV transmission has dramatically reduced the number of children born with HIV worldwide (<xref ref-type="bibr" rid="ref36">De Cock et al., 2000</xref>; <xref ref-type="bibr" rid="ref3">Afran et al., 2014</xref>; <xref ref-type="bibr" rid="ref119">Toledo et al., 2021</xref>; <xref ref-type="bibr" rid="ref129">Wedderburn et al., 2022b</xref>). Consequently, the population of children who are HIV-exposed but uninfected (CHEU) is on the rise, with approximately 16 million CHEU living across the globe currently (<xref ref-type="bibr" rid="ref47">Evans et al., 2016</xref>; <xref ref-type="bibr" rid="ref113">Slogrove et al., 2020</xref>; <xref ref-type="bibr" rid="ref4">AIDSinfo | UNAIDS, 2024</xref>).</p>
<p>While the benefits of ART outweigh the risks, our knowledge of the safety and toxicity of ART in pregnancy is limited, and there is a paucity of information on the ART effects on fetal development and the health trajectory of these children. CHEU are at higher risk for prematurity and growth restriction, both of which are risk factors for developmental delays. Studies have also reported developmental, cognitive, and behavioral delays in CHEU compared to their unexposed peers (<xref ref-type="bibr" rid="ref69">Le Doar&#x00E9; et al., 2012</xref>; <xref ref-type="bibr" rid="ref112">Sirois et al., 2013</xref>; <xref ref-type="bibr" rid="ref92">Nozyce et al., 2014</xref>; <xref ref-type="bibr" rid="ref131">Williams et al., 2016</xref>; <xref ref-type="bibr" rid="ref84">McHenry et al., 2018</xref>; <xref ref-type="bibr" rid="ref16">Boivin et al., 2019</xref>; <xref ref-type="bibr" rid="ref115">Springer et al., 2020</xref>; <xref ref-type="bibr" rid="ref119">Toledo et al., 2021</xref>; <xref ref-type="bibr" rid="ref129">Wedderburn et al., 2022b</xref>; <xref ref-type="bibr" rid="ref133">Yao et al., 2023</xref>). These can lead to poorer academic performance and social interactions, and place these children at risk for persistent problems into adulthood (<xref ref-type="bibr" rid="ref47">Evans et al., 2016</xref>; <xref ref-type="bibr" rid="ref14">Black et al., 2017</xref>; <xref ref-type="bibr" rid="ref84">McHenry et al., 2018</xref>; <xref ref-type="bibr" rid="ref127">Wedderburn et al., 2019a</xref>).</p>
<p>Boosted protease inhibitors administered with a dual nucleoside reverse transcriptase inhibitor (NRTI) backbone are part of recommended regimens for use in pregnancy (<xref ref-type="bibr" rid="ref96">Powis et al., 2019</xref>; see Table 14 in <xref ref-type="bibr" rid="ref1">Department of Health and Human Services, 2024</xref>). <italic>In utero</italic> exposure to protease inhibitors such as atazanavir has been associated with delayed emergence of language, hearing, and lower scores on the Bayley Scale III (<xref ref-type="bibr" rid="ref101">Rice et al., 2013</xref>; <xref ref-type="bibr" rid="ref112">Sirois et al., 2013</xref>; <xref ref-type="bibr" rid="ref56">Himes et al., 2015</xref>; <xref ref-type="bibr" rid="ref38">Desmonde et al., 2016</xref>). Additionally, protease inhibitor-based ART has been associated with higher risk for premature birth particularly with exposure in the first trimester (<xref ref-type="bibr" rid="ref97">Powis et al., 2011</xref>; <xref ref-type="bibr" rid="ref48">Favarato et al., 2018</xref>; <xref ref-type="bibr" rid="ref110">Shinar et al., 2022</xref>), as well as altered <italic>in utero</italic> hormonal environment and placental dysfunction, all of which can influence neurodevelopment (<xref ref-type="bibr" rid="ref43">Dunk and Serghides, 2022</xref>). Exposure to NRTIs has been associated with an increased risk of mitochondrial dysfunction including in the brain of CHEU (<xref ref-type="bibr" rid="ref18">Budd et al., 2018</xref>). A recent study assessing neurodevelopmental outcomes in 5-year-old CHEU reported that those exposed <italic>in utero</italic> to ritonavir-boosted atazanavir (ATV/r) with tenofovir/emtricitabine backbone showed a higher risk of single and multiple neurodevelopmental problems (<xref ref-type="bibr" rid="ref133">Yao et al., 2023</xref>). Although these studies show neurocognitive impairments related to specific antiretroviral drugs, limited studies correlate neurodevelopmental outcomes to specific ART regimens. There is a need to improve our understanding of how perinatal ART exposure affects developmental mechanisms of neurocognition and behavior, to inform selection of ARVs that will optimize maternal and child health.</p>
<p>Investigation of neurocognitive phenotypes in CHEU can be challenging as neurocognitive development can be influenced by multiple factors including environmental and socioeconomic factors. Animal studies enable fundamental and mechanistic studies that are otherwise challenging in human studies. We have previously shown that <italic>in utero</italic> exposure to protease inhibitor-based ART in a mouse model led to somatic growth impairments, olfactory deficits, and delays in primitive reflexes that involve sensory and vestibular motor pathways (<xref ref-type="bibr" rid="ref108">Sarkar et al., 2020</xref>). As perinatal brain development forms a foundation for long-term behavioral, motor, and cognitive outcomes (<xref ref-type="bibr" rid="ref85">Melillo, 2011</xref>), this study focused on the long-term effects of perinatal ART exposure on neurocognitive and motor outcomes. We compared motor performance, anxiety-related behaviors, and hippocampal-dependent memory in adult mice perinatally exposed to either water as a control, or ritonavir-boosted atazanavir (ATV/r) administered with either abacavir/lamivudine (ABC/3TC) or tenofovir disoproxil fumarate/emtricitabine (TDF/FTC). Further, we studied the mechanisms underlying the neurocognitive outcomes using magnetic resonance imaging (MRI), tissue immunofluorescence, and gene expression analysis.</p>
</sec>
<sec sec-type="methods" id="sec6">
<label>2</label>
<title>Methods</title>
<sec id="sec7">
<label>2.1</label>
<title>Ethics statement</title>
<p>Animal experiments conformed to the policies and guidelines of the Canadian Council on Animal Care and were approved by the University Health Network Animal Use Committee.</p>
</sec>
<sec id="sec8">
<label>2.2</label>
<title>Breeding</title>
<p>Male and female (8&#x2009;week-old) C57BL/6&#x2009;J were purchased from Jackson Laboratory. Animals were housed in a temperature-controlled room at 21&#x2009;&#x00B1;&#x2009;1&#x00B0;C and 55&#x2009;&#x00B1;&#x2009;5% relative humidity under a 12-h light/dark cycle. Food and water were provided <italic>ad libitum</italic>. Female mice were trained on gavage using water for 1&#x2009;week prior to mating to reduce gavage-related stress during pregnancy. Two female virgin mice were mated with an experienced male. Mating was confirmed by the presence of vaginal plug. Plugged mice were randomly assigned to one of the three treatment arms: ABC/3TC&#x2009;+&#x2009;ATV/r (100/50&#x2009;mg/kg/day +50/16.6&#x2009;mg/kg/day), TDF/FTC&#x2009;+&#x2009;ATV/r (50&#x2009;mg/33.3/kg/day +50/16.6&#x2009;mg/kg/day), or water as control. Dosing was calculated based on previous pharmacokinetic studies in mice that optimized doses to yield Cmax plasma levels similar to levels reported in humans (<xref ref-type="bibr" rid="ref61">Kala et al., 2018</xref>; <xref ref-type="bibr" rid="ref108">Sarkar et al., 2020</xref>; <xref ref-type="bibr" rid="ref53">Gilmore et al., 2021</xref>; <xref ref-type="bibr" rid="ref11">Balogun and Serghides, 2022</xref>). Mice received daily treatment by oral gavage in a total volume of 100&#x2009;&#x03BC;L, starting on day of plug detection until time of delivery of litter. Pups were kept with their mothers until weaning on postnatal day 21. Pups were then sexed and divided into three arms based on their maternal treatment &#x2013; a total of 55 pups (27 female, 28 male) from 17 litters in the control arm, 48 pups (27 female, 21 males) from 14 litters in the ABC/3TC&#x2009;+&#x2009;ATV/r arm, and 43 pups (21 female, 22 male) from 12 litters from the TDF/FTC&#x2009;+&#x2009;ATV/r arm were included in the behavioral testing.</p>
</sec>
<sec id="sec9">
<label>2.3</label>
<title>Behavioral testing</title>
<p>Animals were tested in the following battery of tests in the order presented in <xref ref-type="fig" rid="fig1">Figure 1</xref>, beginning at 6&#x2009;weeks and ending at 8&#x2009;months of age (N&#x2009;=&#x2009;21&#x2013;28 for all treatment groups). All testing took place in an empty behavioral testing room absent of spatial or visual cues. Mice were brought to the testing arena in their home cage and were tested individually. Between tests, the testing cage was thoroughly cleaned with Virox5 (Johnson Diversey, Inc., Sturevant, WI, United States) to eliminate odor cues.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Schematic diagram of experimental design and behavioral tests in mice. <bold>(A)</bold> Pregnant mice were randomly assigned treatment groups of ritonavir-boosted atazanavir combined with either abacavir/lamivudine (ABC/3TC&#x2009;+&#x2009;ATV/r), or tenofovir/emtricitabine (TDF/FTC&#x2009;+&#x2009;ATV/r) and water as control from gestational day 0.5. Behavioral testing was conducted from 6&#x2009;weeks postnatally followed by brain analyses including quantitative real-time PCR, immunohistochemistry, and magnetic resonance imaging (MRI). <bold>(B)</bold> List of behavioral tests performed on <italic>in utero</italic> exposed mice and the behaviors assessed by the respective tests.</p>
</caption>
<graphic xlink:href="fnmol-17-1376681-g001.tif"/>
</fig>
<p>The Open Field Test: The open field test was used to assess exploratory and locomotor behavior, and to assess response to open field stress. Animals were placed in a clean, empty open field (40&#x2009;cm x 40&#x2009;cm x 50&#x2009;cm) made of plywood painted white on the inside floor and walls and black on the outside walls with non-toxic acrylic paint. Animals freely explored the maze for 30&#x2009;min and their behavior was recorded using ANYMAZE<sup>&#x00AE;</sup> and ODLog<sup>&#x2122;</sup> software. Lighting levels were 330 lux. The following behaviors were coded: immobility; grooming (engaged in self-cleaning behavior), rearing (both front paws raised off of the floor), locomotion (total distance traveled and speed of travel), time spent in the center, and time spent by the wall (thigmotaxis zone).</p>
<p>The Zero Maze Test: Mice were removed from their home cage in the testing room and placed at the entrance of an enclosed region of the maze. Each mouse was allowed to freely explore the maze for a 5-min period after which it was returned immediately to its home cage. Tests were video recorded using ANYMAZE<sup>&#x00AE;</sup> software. Lighting levels were 330 lux. The total time spent in the enclosed and unenclosed arms were coded and a percentage of time spent in the open arms was calculated.</p>
<p>Light/Dark Box Test: This test assesses unconditioned anxiety responses in mice. The light/dark box has 2 compartments separated by a 7&#x2009;cm door - a light area (2/3 of the area) and a dark area (1/3 of the area; <xref ref-type="bibr" rid="ref17">Bourin and Hasco&#x00EB;t, 2003</xref>). Each mouse was placed in the light area and allowed to freely explore for 10&#x2009;min. The time spent in each of the areas was recorded. Tests were video recorded using ANYMAZE<sup>&#x00AE;</sup> software. Lighting levels in the light box were 580 lux.</p>
<p>The Novel Object Recognition Test: Mice are habituated to the testing arena (clear plastic mouse cages) for 15&#x2009;min over 7 daily sessions and were considered successfully habituated when they consumed a small piece of breakfast cereal (Fruit Loops) within 2&#x2009;min of the entrance to the testing arena. On the novel object recognition test day, each animal was exposed for 10&#x2009;min to a LEGO<sup>&#x00AE;</sup> construct (single LEGO brick; LEGO Group, Billund, Denmark) and a Hot Wheels<sup>&#x00AE;</sup> car (model Corvette Z06; Mattel, Inc., El Segundo, CA, United States). The objects were previously determined to be of matched saliency in mice. Objects were fixed to the floor of the mouse cage with magnets. All tests were recorded using ANYMAZE<sup>&#x00AE;</sup> software. Time spent exploring the objects was recorded using ODLog<sup>&#x2122;</sup> software. Exploration was scored when the mouse touched an object with its forepaws or snout, bit, licked, or sniffed the object from a distance of no more than 1.5&#x2009;cm. Following a 3-h delay, mice were re-exposed for 5&#x2009;min to one object from the original test pair and to a novel object. The position and shape of the novel object was counterbalanced between treatment groups to control for bias. Lighting levels during all testing were 330 lux.</p>
<p>The 3-Chamber Social Approach Test: The test was done according to the following method (<xref ref-type="bibr" rid="ref60">Kaidanovich-Beilin et al., 2011</xref>). Lighting levels during testing were 330 lux. Briefly, the sociability test was initiated by habituating the test mouse to an empty 3-room-chamber apparatus for 5&#x2009;min. An unfamiliar mouse (same sex, background, age, and weight as the test mouse)&#x2014;stranger 1&#x2014;was placed in a wire cup in one room of the 3-room chamber. An empty wire cup was placed in the opposite room. The test mouse was released in the middle room and had free access to explore the rooms. The duration and frequency of direct contacts between the test mouse and the empty wire cup or the wire cup housing the unfamiliar mouse were recorded for 10&#x2009;min. Following the sociability test, the social novelty test was initiated by placing a second unfamiliar mouse&#x2014;stranger 2&#x2014;in an identical wire cup in the opposite chamber for 10&#x2009;min. The duration and frequency of direct contacts between the test mouse and the wire cup housing the familiar mouse (stranger 1) or the wire cup housing the novel mouse (stranger 2) were recorded for 10&#x2009;min. Normal sociability for a mouse is to prefer to spend time with another mouse rather than the empty cup, and also show preference for social novelty; any deviation from this indicates impaired sociability (<xref ref-type="bibr" rid="ref60">Kaidanovich-Beilin et al., 2011</xref>). A &#x201C;sociability index&#x201D; was calculated as (T<sub>S1</sub>-T<sub>WC</sub>)/(T<sub>S1</sub>&#x2009;+&#x2009;T<sub>WC</sub>), wherein &#x201C;T<sub>S1</sub>&#x201D; represents the duration spent with stranger 1 and &#x201C;T<sub>WC</sub>&#x201D; the duration spent exploring empty wire cup. A &#x201C;social novelty index&#x201D; was calculated as (T<sub>S1</sub>-T<sub>S2</sub>)/(T<sub>S1</sub>&#x2009;+&#x2009;T<sub>S2</sub>), wherein &#x201C;T<sub>S1</sub>&#x201D; represents the duration spent with stranger 1 and &#x201C;T<sub>S2</sub>&#x201D; the duration spent with stranger 2 or novel mouse.</p>
<p>Brain collection: At 8&#x2009;months of age, following completion of all behavioral testing, mice were sacrificed and brains were collected for use in either magnetic resonance imaging, immunofluorescence imaging, or expression analyses.</p>
</sec>
<sec id="sec10">
<label>2.4</label>
<title>Magnetic resonance imaging</title>
<p>Sample preparation: To prepare the brains for neuroanatomical assessment, mice underwent trans-cardiac perfusion (<italic>N</italic>&#x2009;=&#x2009;14&#x2013;24 per treatment group; <xref ref-type="bibr" rid="ref22">Cahill et al., 2012</xref>). Briefly, mice were anesthetized with ketamine/xylazine and perfused through the left ventricle with 30&#x2009;mL PBS and 2&#x2009;mM ProHance (Bracco Diagnostics, Inc., NJ, United States), followed by 30&#x2009;mL of 4% Paraformaldehyde (PFA) and 2&#x2009;mM ProHance. The brains within the skull were incubated in 4% PFA containing 2&#x2009;mM ProHance overnight at 4&#x00B0;C and then stored in a solution containing PBS, 2&#x2009;mM ProHance, and 0.01% sodium azide for at least 28&#x2009;days before imaging (<xref ref-type="bibr" rid="ref37">de Guzman et al., 2016</xref>).</p>
<p>Imaging: A multi-channel 7.0&#x2009;T magnet (Varian Inc. Palo Alto, CA, United States) and a custom-built solenoid array were used to image 16 samples in parallel (<xref ref-type="bibr" rid="ref34">Dazai et al., 2011</xref>). An anatomical scan was performed using a T2-weighted, 3D fast spin-echo sequence with a cylindrical k-space acquisition and the following parameters: TR&#x2009;=&#x2009;350&#x2009;ms, TE&#x2009;=&#x2009;12&#x2009;ms, echo train length&#x2009;=&#x2009;6, four averages, field-of-view 20&#x2009;mm x 20&#x2009;mm x 25&#x2009;mm, matrix size&#x2009;=&#x2009;504 &#x00D7; 504 &#x00D7; 630, isotropic image resolution&#x2009;=&#x2009;40&#x2009;&#x03BC;m (<xref ref-type="bibr" rid="ref114">Spencer Noakes et al., 2017</xref>). Five control and one ABC/3TC&#x2009;+&#x2009;ATV/r brain had to be excluded from analysis because of damage during preparation for imaging or image misregistration.</p>
<p>Volume analysis: An automated image registration approach implemented in the Pydpiper toolkit (<xref ref-type="bibr" rid="ref52">Friedel et al., 2014</xref>) and using the Advanced Normalization Tools (ANTs) deformation algorithm (<xref ref-type="bibr" rid="ref9">Avants et al., 2008</xref>) was used. The 53 MR images were registered together through a process of linear and non-linear steps to create an average image (<xref ref-type="bibr" rid="ref90">Nieman et al., 2018</xref>). The registration yielded deformation fields for each brain, and the absolute and relative Jacobian determinants provided an estimate of the local volume changes at every voxel for comparison between the groups (<xref ref-type="bibr" rid="ref30">Chung et al., 2001</xref>). Using the results of the linear alignment, multiple templates of a segmented anatomical atlas with 182 labeled structures (<xref ref-type="bibr" rid="ref42">Dorr et al., 2008</xref>; <xref ref-type="bibr" rid="ref120">Ullmann et al., 2013</xref>; <xref ref-type="bibr" rid="ref116">Steadman et al., 2014</xref>) were created (the MAGeT procedure; <xref ref-type="bibr" rid="ref27">Chakravarty et al., 2013</xref>). From the final voted segmentation, volume changes were calculated and expressed in absolute volumes (mm<sup>3</sup>). These volumes were then normalized to total brain volume.</p>
</sec>
<sec id="sec11">
<label>2.5</label>
<title>Tissue immunofluorescence and image analysis</title>
<p>Immunofluorescence studies were performed on paraffin-embedded fixed brain tissue (<italic>N</italic>&#x2009;=&#x2009;10 for all treatment groups). Mice were anesthetized and perfused through the left ventricle with 30&#x2009;mL PBS, followed by 30&#x2009;mL of 4% PFA. The brains were then extracted, post-fixed in 4% PFA overnight at 4&#x00B0;C and then stored in a solution containing PBS and 0.01% sodium azide. Brains were processed and embedded in paraffin, and then coronally sectioned (6 um thick) and mounted on Superfrost Plus slides (20 slides series with 4 slices per slide). Antigen retrieval was performed by boiling slides in citrate buffer using a microwave (4&#x2009;min at power 6 followed by a cool down and again at 3&#x2009;min at power 6). Slides were then incubated in DAKO serum-free blocking solution (Agilent Technologies) for 45&#x2009;min at room temperature, followed by incubation with primary antibodies suspended in PBS, either NeuN at 1:200 (Abcam; ab177487), or GFAP at 1:1000 (Abcam; ab4674) for 18&#x2013;24&#x2009;h at 4&#x00B0;C. Slides were washed in PBS for 9&#x2009;min, and incubated with appropriate secondary antibodies conjugated to Alexa 488 or Alexa 647 (Abcam), and DAPI (4&#x2032;,6 diamidino-2-phenylindole) for 1.5&#x2009;h at room temperature. Prolong Diamond antifade mounting medium was used (ThermoFisher P36961). Slides were scanned with a Zeiss Axioscan 7 microscope slide scanner (ZEISS) at 20x objective, and images were analyzed. For counts, total number of cells were counted in every 6th section to ensure the same neurons were not counted in two sections, and the sections counted spanned the hippocampus (Bregma coordinates &#x2212;1.35 to &#x2212;2.6; <xref ref-type="bibr" rid="ref78">Malberg et al., 2000</xref>) For neuronal counts, NeuN positive cells in the pyramidal layers of CA1 and dentate gyrus were manually counted on ImageJ software. For glial cells, GFAP positive cells co-labeled with DAPI were counted manually using Zen 3.6 Blue software (ZEISS) in the dendritic layers of CA1 and molecular layers of dentate gyrus. All data are reported as the mean&#x2009;&#x00B1;&#x2009;SEM.</p>
</sec>
<sec id="sec12">
<label>2.6</label>
<title>RNA isolation and quantitative PCR</title>
<p>Brains were collected and dissected into specific regions and then snap frozen (N&#x2009;=&#x2009;20&#x2013;25 per treatment group). For this study, we isolated total RNA from the hippocampus using the MirVana kit (ThermoFisher AM1560) according to the manufacturer&#x2019;s instructions. RNA quality and concentration were determined using the Nano-Drop1000 Spectrophotometer (Thermo Fisher Scientific). RNA was treated with DNase I to remove genomic DNA and reverse transcribed into cDNA using iScript<sup>&#x2122;</sup> cDNA Synthesis Kit (Biorad 1,725,035) according to the manufacturer&#x2019;s instructions. Target gene mRNA levels were assessed by quantitative PCR using SsoAdvanced Universal SYBR Green Supermix master mix (Biorad 1,725,270) and the CFX Opus RT-PCR System. The primer sequences for genes are shown in <xref ref-type="table" rid="tab1">Table 1</xref>. Each reaction contained either 50 or 100&#x2009;ng of cDNA, 1.24&#x2009;&#x03BC;L of forward and reverse primers, and 3&#x2009;&#x03BC;L of SYBR and was run in triplicate. The cycling conditions were as follows: 95&#x00B0;C &#x2013; 3&#x2009;min, 95&#x00B0;C &#x2013; 10s, 60&#x00B0;C &#x2013; 15&#x2009;s, 72&#x00B0;C &#x2013; 15&#x2009;s, repeat 44 times, 65&#x00B0;C &#x2013; 5&#x2009;s, 95&#x00B0;C &#x2013; 0.5&#x00B0;C/cycle. Gene expression was normalized to the geometric mean of 3 housekeeping genes (HPRT, TBP, and PPIA). Relative expression of target genes was obtained using the 2&#x0394;&#x0394;CT method (<xref ref-type="bibr" rid="ref75">Livak and Schmittgen, 2001</xref>).</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Primer sequences.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Gene</th>
<th align="left" valign="top">Forward primer</th>
<th align="left" valign="top">Reverse primer</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">GluA1</td>
<td align="left" valign="top">CCCTGAGAGGTCCCGTAAAC</td>
<td align="left" valign="top">GCTCAGAGCACTGGTCTTGT</td>
</tr>
<tr>
<td align="left" valign="top">GluA2</td>
<td align="left" valign="top">CTACGAGTGGCACACTGAGG</td>
<td align="left" valign="top">CCCAGAGAGAGATCTTGGCG</td>
</tr>
<tr>
<td align="left" valign="top">GLUN2A</td>
<td align="left" valign="top">CAAATTCAACCAGAGGGGCG</td>
<td align="left" valign="top">TGGCAAAGATGTACCCGCTC</td>
</tr>
<tr>
<td align="left" valign="top">GLUN2B</td>
<td align="left" valign="top">CCTCCTGTGTGAGAGGAAAG</td>
<td align="left" valign="top">CTCTGTGTGGAGAAGCTGGG</td>
</tr>
<tr>
<td align="left" valign="top">PSD95</td>
<td align="left" valign="top">AGCCCCAGGATATGTGAACG</td>
<td align="left" valign="top">TCACCGATGTGTGGGTTGTC</td>
</tr>
<tr>
<td align="left" valign="top">TrkB FL</td>
<td align="left" valign="top">GACATTCCAAGTTTGGCATGAAAGG</td>
<td align="left" valign="top">AGAAGATGGAGTGTTACTCCCATT</td>
</tr>
<tr>
<td align="left" valign="top">TrkB TR</td>
<td align="left" valign="top">GCTGGTGATGTTGCTCCTGC</td>
<td align="left" valign="top">CCATCCAGTGGGATCTTATGAAAC</td>
</tr>
<tr>
<td align="left" valign="top">BDNF</td>
<td align="left" valign="top">CTCAGGCAGAATGAGCAATG</td>
<td align="left" valign="top">AGCCGTCTGTGCTCTTCACT</td>
</tr>
<tr>
<td align="left" valign="top">HPRT</td>
<td align="left" valign="top">AGCGTCGTGATTAGCGATGA</td>
<td align="left" valign="top">ACACTTTTTCCAAATCCTCGG</td>
</tr>
<tr>
<td align="left" valign="top">TBP</td>
<td align="left" valign="top">CCTTGTACCCTTCACCAATGAC</td>
<td align="left" valign="top">ACAGCCAAGATTCACGGTAGA</td>
</tr>
<tr>
<td align="left" valign="top">PPIA</td>
<td align="left" valign="top">CCAGGGTGGTGACTTTACAC</td>
<td align="left" valign="top">ATGCTTGCCATCCAGCCA</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec13">
<label>2.7</label>
<title>Statistical analyses</title>
<p>Statistical analyses were performed using Prism (v8.2) and Stata (v13). All behavioral and expression data analyses were performed stratified by sex, and means with SEM were calculated. Differences in mean with 95% confidence intervals between the control group and the ART arms were calculated using mixed effects linear models with robust standard errors that included treatment as a categorical fixed effect, and litter as a random variable to account for litter effects. Neuronal and glial count data are shown as violin plots with individual data points displayed. Differences were assessed using Student&#x2019;s t-test. The Pearson r test was used to assess correlations. MRI data analysis was performed using the R statistical software<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref> and the RMINC package.<xref ref-type="fn" rid="fn0002"><sup>2</sup></xref> For the adult brain MR images, sex was included as a fixed effect. Multiple comparisons were controlled for using the false discovery rate (FDR; Genovese NeuroImage 2002, 15:870&#x2013;878) and statistical significance was defined at an FDR threshold of 1%.</p>
</sec>
</sec>
<sec sec-type="results" id="sec14">
<label>3</label>
<title>Results</title>
<p>The experimental design is shown in <xref ref-type="fig" rid="fig1">Figure 1A</xref>. Male and female mice exposed <italic>in utero</italic> to either control (water), ABC/3TC&#x2009;+&#x2009;ATV/r, or TDF/FTC&#x2009;+&#x2009;ATV/r were tested with a battery of behavioral tests to assess the motor, cognitive, and social abilities starting at 6&#x2009;weeks of age (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Means with standard error of mean for each behavioral test by treatment group are shown in <xref ref-type="table" rid="tab2">Table 2</xref>. The impact of <italic>in utero</italic> ART exposure on performance in each test was assess using a mixed effects linear model that included treatment as a categorical fixed effect with control-treatment as the reference, and litter as a random variable to account for litter effects. Analyses were stratified by sex, and data are shown as the difference in mean with 95% confidence interval compared to control (summarized in <xref ref-type="supplementary-material" rid="SM1">Supplementary Table S1</xref>). The raw data for the behavioral tests are shown in <xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S1</xref> and <xref ref-type="supplementary-material" rid="SM1">S2</xref>. Birth weight (measured at postnatal day 3) was lower in the ABC/3TC&#x2009;+&#x2009;ATV/r compared to the other treatment groups (median (interquartile range) with <italic>p</italic>-value vs. control: for males&#x2014;control: 1.72&#x2009;g (1.62, 1.80), ABC/3TC&#x2009;+&#x2009;ATV/r: 1.44&#x2009;g (1.35, 1.74), <italic>p</italic>&#x2009;=&#x2009;0.018, TDF/FTC&#x2009;+&#x2009;ATV/r: 1.64&#x2009;g (1.45, 1.82), <italic>p</italic>&#x2009;=&#x2009;0.28; for females &#x2013; control: 1.58&#x2009;g (1.42, 1.79), ABC/3TC&#x2009;+&#x2009;ATV/r: 1.49&#x2009;g (1.31, 1.65), <italic>p</italic>&#x2009;=&#x2009;0.083, TDF/FTC&#x2009;+&#x2009;ATV/r: 1.60&#x2009;g (1.43, 1.98), <italic>p</italic>&#x2009;=&#x2009;0.65). To account for possible contributions of lower birth weight on behavioral scores, analyses were repeated adjusting for weight at postnatal day 3. The adjusted difference in mean with 95% confidence interval compared to control are shown in <xref ref-type="supplementary-material" rid="SM1">Supplementary Table S2</xref>. In general, adjusting for weight did not impact on behavioral differences between treatment groups. At 8&#x2009;months, mice were sacrificed and assessed for morphological and physiological changes in the brain using MRI, immunohistochemistry, and real-time quantitative PCR.</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Means with standard error of mean (SEM) for behavioral test by treatment group.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="top" colspan="2">Control<break/>Mean&#x2009;&#x00B1;&#x2009;SEM</th>
<th align="center" valign="top" colspan="2">ABC/3TC&#x2009;+&#x2009;ATV/r<break/>Mean&#x2009;&#x00B1;&#x2009;SEM</th>
<th align="center" valign="top" colspan="2">TDF/FTC&#x2009;+&#x2009;ATV/r<break/>Mean&#x2009;&#x00B1;&#x2009;SEM</th>
</tr>
<tr>
<th/>
<th align="center" valign="top"><italic>M</italic></th>
<th align="center" valign="top"><italic>F</italic></th>
<th align="center" valign="top"><italic>M</italic></th>
<th align="center" valign="top"><italic>F</italic></th>
<th align="center" valign="top"><italic>M</italic></th>
<th align="center" valign="top"><italic>F</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" colspan="7">Open field maze</td>
</tr>
<tr>
<td align="left" valign="top"><italic>Total distance (m)</italic></td>
<td align="center" valign="top">37.8&#x2009;&#x00B1;&#x2009;2.1</td>
<td align="center" valign="top">47.0&#x2009;&#x00B1;&#x2009;2.7</td>
<td align="center" valign="top">36.3&#x2009;&#x00B1;&#x2009;1.7</td>
<td align="center" valign="top">39.1&#x2009;&#x00B1;&#x2009;3.0</td>
<td align="center" valign="top">50.4&#x2009;&#x00B1;&#x2009;3.2&#x002A;</td>
<td align="center" valign="top">55.4&#x2009;&#x00B1;&#x2009;3.3&#x002A;</td>
</tr>
<tr>
<td align="left" valign="top"><italic>Mobile time (s)</italic></td>
<td align="center" valign="top">265.3&#x2009;&#x00B1;&#x2009;12.5</td>
<td align="center" valign="top">326.0&#x2009;&#x00B1;&#x2009;15.4</td>
<td align="center" valign="top">253.4&#x2009;&#x00B1;&#x2009;11.3</td>
<td align="center" valign="top">264.9&#x2009;&#x00B1;&#x2009;20.3</td>
<td align="center" valign="top">330.1&#x2009;&#x00B1;&#x2009;16.7&#x002A;</td>
<td align="center" valign="top">370.6&#x2009;&#x00B1;&#x2009;17.3</td>
</tr>
<tr>
<td align="left" valign="top"><italic>Rearing (s)</italic></td>
<td align="center" valign="top">79.3&#x2009;&#x00B1;&#x2009;7.5</td>
<td align="center" valign="top">98.1&#x2009;&#x00B1;&#x2009;10.3</td>
<td align="center" valign="top">76.6&#x2009;&#x00B1;&#x2009;7.2</td>
<td align="center" valign="top">78.6&#x2009;&#x00B1;&#x2009;7.0</td>
<td align="center" valign="top">161.2&#x2009;&#x00B1;&#x2009;11.9&#x002A;&#x002A;&#x002A;</td>
<td align="center" valign="top">170.9&#x2009;&#x00B1;&#x2009;9.3&#x002A;&#x002A;&#x002A;</td>
</tr>
<tr>
<td align="left" valign="top"><italic>Grooming (s)</italic></td>
<td align="center" valign="top">50.7&#x2009;&#x00B1;&#x2009;5.6</td>
<td align="center" valign="top">38.2&#x2009;&#x00B1;&#x2009;3.6</td>
<td align="center" valign="top">66.5&#x2009;&#x00B1;&#x2009;7.4</td>
<td align="center" valign="top">70.2&#x2009;&#x00B1;&#x2009;9.2&#x002A;&#x002A;&#x002A;</td>
<td align="center" valign="top">36.1&#x2009;&#x00B1;&#x2009;4.2&#x002A;</td>
<td align="center" valign="top">26.9&#x2009;&#x00B1;&#x2009;2.8&#x002A;</td>
</tr>
<tr>
<td align="left" valign="top"><italic>Wall time (s)</italic></td>
<td align="center" valign="top">828.5&#x2009;&#x00B1;&#x2009;7.6</td>
<td align="center" valign="top">835.7&#x2009;&#x00B1;&#x2009;6.1</td>
<td align="center" valign="top">821.9&#x2009;&#x00B1;&#x2009;54.6</td>
<td align="center" valign="top">826.0&#x2009;&#x00B1;&#x2009;9.4</td>
<td align="center" valign="top">835.2&#x2009;&#x00B1;&#x2009;7.3</td>
<td align="center" valign="top">845.8&#x2009;&#x00B1;&#x2009;5.6</td>
</tr>
<tr>
<td align="left" valign="top"><italic>Center time (s)</italic></td>
<td align="center" valign="top">69.9&#x2009;&#x00B1;&#x2009;8.0</td>
<td align="center" valign="top">62.4&#x2009;&#x00B1;&#x2009;6.1</td>
<td align="center" valign="top">67.0&#x2009;&#x00B1;&#x2009;10.3</td>
<td align="center" valign="top">68.9&#x2009;&#x00B1;&#x2009;6.8</td>
<td align="center" valign="top">63.6&#x2009;&#x00B1;&#x2009;6.7</td>
<td align="center" valign="top">60.7&#x2009;&#x00B1;&#x2009;5.5</td>
</tr>
<tr>
<td align="left" valign="top" colspan="7">Light/dark box</td>
</tr>
<tr>
<td align="left" valign="top"><italic>Time in light box (s)</italic></td>
<td align="center" valign="top">188.3&#x2009;&#x00B1;&#x2009;10.8</td>
<td align="center" valign="top">169.8&#x2009;&#x00B1;&#x2009;6.9</td>
<td align="center" valign="top">190.0&#x2009;&#x00B1;&#x2009;13.1</td>
<td align="center" valign="top">167. 6&#x2009;&#x00B1;&#x2009;9.8</td>
<td align="center" valign="top">209.8&#x2009;&#x00B1;&#x2009;7.7</td>
<td align="center" valign="top">202.4&#x2009;&#x00B1;&#x2009;7.1&#x002A;&#x002A;</td>
</tr>
<tr>
<td align="left" valign="top" colspan="7">Zero maze</td>
</tr>
<tr>
<td align="left" valign="top"><italic>Time in open area (s)</italic></td>
<td align="center" valign="top">34.5&#x2009;&#x00B1;&#x2009;3.6</td>
<td align="center" valign="top">42.7&#x2009;&#x00B1;&#x2009;4.2</td>
<td align="center" valign="top">47.4&#x2009;&#x00B1;&#x2009;4.3&#x002A;</td>
<td align="center" valign="top">51.7&#x2009;&#x00B1;&#x2009;3.5</td>
<td align="center" valign="top">55.6&#x2009;&#x00B1;&#x2009;4.8&#x002A;&#x002A;&#x002A;</td>
<td align="center" valign="top">57.0&#x2009;&#x00B1;&#x2009;4.2</td>
</tr>
<tr>
<td align="left" valign="top" colspan="7">Novel object recognition</td>
</tr>
<tr>
<td align="left" valign="top"><italic>Exploration time (s)</italic></td>
<td align="center" valign="top">113.8&#x2009;&#x00B1;&#x2009;9.2</td>
<td align="center" valign="top">139&#x2009;&#x00B1;&#x2009;13.8</td>
<td align="center" valign="top">121.1&#x2009;&#x00B1;&#x2009;7.5</td>
<td align="center" valign="top">111.3&#x2009;&#x00B1;&#x2009;7.9</td>
<td align="center" valign="top">165.9&#x2009;&#x00B1;&#x2009;8.3&#x002A;&#x002A;</td>
<td align="center" valign="top">219.5&#x2009;&#x00B1;&#x2009;8.3&#x002A;&#x002A;&#x002A;</td>
</tr>
<tr>
<td align="left" valign="top"><italic>Time with novel object (s)</italic></td>
<td align="center" valign="top">45.0&#x2009;&#x00B1;&#x2009;3.7</td>
<td align="center" valign="top">44.7&#x2009;&#x00B1;&#x2009;3.6</td>
<td align="center" valign="top">29.4&#x2009;&#x00B1;&#x2009;3.0&#x002A;&#x002A;&#x002A;</td>
<td align="center" valign="top">30.0&#x2009;&#x00B1;&#x2009;3.0</td>
<td align="center" valign="top">42.8&#x2009;&#x00B1;&#x2009;1.9</td>
<td align="center" valign="top">56.0&#x2009;&#x00B1;&#x2009;4.0</td>
</tr>
<tr>
<td align="left" valign="top"><italic>Memory Index</italic></td>
<td align="center" valign="top">0.22&#x2009;&#x00B1;&#x2009;0.03</td>
<td align="center" valign="top">0.19&#x2009;&#x00B1;&#x2009;0.03</td>
<td align="center" valign="top">0.036&#x2009;&#x00B1;&#x2009;0.06&#x002A;</td>
<td align="center" valign="top">&#x2212;0.0003&#x2009;&#x00B1;&#x2009;0.04&#x002A;&#x002A;&#x002A;</td>
<td align="center" valign="top">0.11&#x2009;&#x00B1;&#x2009;0.03&#x002A;&#x002A;</td>
<td align="center" valign="top">0.089&#x2009;&#x00B1;&#x2009;0.03&#x002A;&#x002A;</td>
</tr>
<tr>
<td align="left" valign="top" colspan="7">Social approach</td>
</tr>
<tr>
<td align="left" valign="top"><italic>Sociability Index</italic></td>
<td align="center" valign="top">0.27&#x2009;&#x00B1;&#x2009;0.05</td>
<td align="center" valign="top">0.23&#x2009;&#x00B1;&#x2009;0.03</td>
<td align="center" valign="top">0.33&#x2009;&#x00B1;&#x2009;0.06</td>
<td align="center" valign="top">0.25&#x2009;&#x00B1;&#x2009;0.04</td>
<td align="center" valign="top">0.18&#x2009;&#x00B1;&#x2009;0.05</td>
<td align="center" valign="top">0.14&#x2009;&#x00B1;&#x2009;0.04&#x002A;&#x002A;</td>
</tr>
<tr>
<td align="left" valign="top"><italic>Social Novelty Index</italic></td>
<td align="center" valign="top">0.43&#x2009;&#x00B1;&#x2009;0.04</td>
<td align="center" valign="top">0.42&#x2009;&#x00B1;&#x2009;0.05</td>
<td align="center" valign="top">0.48&#x2009;&#x00B1;&#x2009;0.07</td>
<td align="center" valign="top">0.25&#x2009;&#x00B1;&#x2009;0.05&#x002A;&#x002A;</td>
<td align="center" valign="top">0.47&#x2009;&#x00B1;&#x2009;0.05</td>
<td align="center" valign="top">0.33&#x2009;&#x00B1;&#x2009;0.05</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>Statistical comparisons stratified by sex using mixed effects linear models with robust standard errors that included treatment as a categorical fixed effect, and litter as a random variable to account for litter effects. All comparison vs. control. &#x002A;<italic>p</italic> &#x003C;&#x2009;0.05, &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001.</p>
</table-wrap-foot>
</table-wrap>
<sec id="sec15">
<label>3.1</label>
<title><italic>In utero</italic> exposure to TDF/FTC&#x2009;+&#x2009;ATV/r is associated with increased locomotor activity and exploratory behavior, and reduced anxiety</title>
<p>Some studies suggest altered motor skills and increased levels of anxiety in CHEU (<xref ref-type="bibr" rid="ref29">Chase et al., 2000</xref>; <xref ref-type="bibr" rid="ref130">Wedderburn et al., 2019b</xref>, <xref ref-type="bibr" rid="ref128">2022a</xref>,<xref ref-type="bibr" rid="ref129">b</xref>; <xref ref-type="bibr" rid="ref133">Yao et al., 2023</xref>). We first assessed locomotor activity, anxiety, and exploration using the open-field test. Both male and female TDF/FTC&#x2009;+&#x2009;ATV/r-exposed mice showed increased distance traveled (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, difference in mean from control for male +12.8&#x2009;m <italic>p</italic>&#x2009;=&#x2009;0.01, for female +8.1&#x2009;m, <italic>p</italic>&#x2009;=&#x2009;0.04) compared to control and ABC/3TC&#x2009;+&#x2009;ATV/r-exposed mice. Both male and female TDF/FTC&#x2009;+&#x2009;ATV/r exposed mice also showed increased mobile time compared to control and ABC/3TC&#x2009;+&#x2009;ATV/r, although this only reached significance for the males (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, difference in mean from control for male TDF/FTC&#x2009;+&#x2009;ATV/r&#x2009;+&#x2009;66.5&#x2009;s, <italic>p</italic>&#x2009;=&#x2009;0.01, for female +41.4&#x2009;s, <italic>p</italic>&#x2009;=&#x2009;0.07). When we adjusted for weight at postnatal day 3, the increase in mobile time seen in the TDF/FTC&#x2009;+&#x2009;ATV/r-exposed females did reach significance (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table S2</xref>). No difference was observed in distance traveled between ABC/3TC&#x2009;+&#x2009;ATV/r-exposed mice and controls for either sex, although female ABC/3TC&#x2009;+&#x2009;ATV/r-exposed mice had a lower mobile time compared to controls that did not reach significance (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Time spent in the center and time spent by the wall (thigmotaxis zone) were similar between groups (<xref ref-type="table" rid="tab2">Table 2</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary Table S1</xref>). These data suggest an increased locomotor activity and exploratory drive with TDF/FTC&#x2009;+&#x2009;ATV/r, but not with ABC/3TC&#x2009;+&#x2009;ATV/r exposure.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p><italic>In utero</italic> exposure to TDF/FTC&#x2009;+&#x2009;ATV/r is associated with increased locomotor activity and exploratory behavior. Difference in mean performance from control (indicated as the dotted line) with 95% confidence intervals are shown for male and female mice exposed to ABC/3TC&#x2009;+&#x2009;ATV/r (red dots) or TDF/FTC&#x2009;+&#x2009;ATV/r (blue dots) for the open field test <bold>(A&#x2013;D)</bold>, light/dark chamber test <bold>(G)</bold> and zero maze test <bold>(H)</bold>. For the open field test we show difference in mean <bold>(A)</bold> distance traveled, <bold>(B)</bold> time mobile, <bold>(C)</bold> rearing time, and <bold>(D)</bold> grooming time. We also show correlation between rearing and distance traveled <bold>(E)</bold> and between grooming time and distance traveled <bold>(F)</bold>. For the light/dark chamber test we show difference in mean time spent in the light box <bold>(G)</bold>. For the zero maze test we show difference in mean time spent in the open area <bold>(H)</bold>. Mixed effects linear models with robust standard errors were fit to estimate the difference in mean performance, 95% confidence intervals, and <italic>p</italic>-values between ART-exposed mice and controls for each test metric. Litter was included as a random variable to account for litter variability. Correlations by Pearson r. For males: <italic>n</italic>&#x2009;=&#x2009;21 from 6 litters for ABC/3TC&#x2009;+&#x2009;ATV/r, <italic>n</italic>&#x2009;=&#x2009;22 from 6 litters for TDF/FTC&#x2009;+&#x2009;ATV/r, and <italic>n</italic>&#x2009;=&#x2009;28 from 9 litters for control. For females: <italic>n</italic>&#x2009;=&#x2009;27 from 8 litters for ABC/3TC&#x2009;+&#x2009;ATV/r, <italic>n</italic>&#x2009;=&#x2009;21 from 6 litters for TDF/FTC&#x2009;+&#x2009;ATV/r, <italic>n</italic>&#x2009;=&#x2009;27 from 9 litters for control. &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001. ABC, abacavir; 3TC, lamivudine; TDF, tenofovir; FTC, emtricitabine; ATV/r. ritonavir-boosted atazanavir.</p>
</caption>
<graphic xlink:href="fnmol-17-1376681-g002.tif"/>
</fig>
<p>We also assessed rearing time in the open field test, another indicator of locomotor activity, exploration, and anxiety. Increased rearing was observed in both male and female TDF/FTC&#x2009;+&#x2009;ATV/r-exposed mice compared to the other groups, again suggesting increased activity and reduced anxiety (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, difference in mean from control for male TDF/FTC&#x2009;+&#x2009;ATV/r&#x2009;+&#x2009;80.6&#x2009;s, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001, for female +70.2&#x2009;s, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001). Rearing time did not differ significantly between the ABC/3TC&#x2009;+&#x2009;ATV/r-exposed mice and controls.</p>
<p>Next, we assessed grooming in the open field. Grooming in rodents is a natural response to displacement which is often exhibited upon exposure to a novel environment. In a stressful environment with a high anxiety level, rodents tend to groom longer than usual (<xref ref-type="bibr" rid="ref46">Estanislau, 2012</xref>; <xref ref-type="bibr" rid="ref62">Kalueff et al., 2016</xref>; <xref ref-type="bibr" rid="ref73">Liu et al., 2021</xref>). Both male and female ABC/3TC&#x2009;+&#x2009;ATV/r-exposed mice spent more time grooming compared to controls and TDF/FTC&#x2009;+&#x2009;ATV/r-exposed mice, although this only reached significance for the female mice (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, difference in mean from control for male ABC/3TC&#x2009;+&#x2009;ATV/r&#x2009;+&#x2009;16.6&#x2009;s, <italic>p</italic>&#x2009;=&#x2009;0.1, for female +32.6&#x2009;s, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001), suggesting greater anxiety with ABC/3TC&#x2009;+&#x2009;ATV/r exposure. Supporting a phenotype of reduced anxiety, TDF/FTC&#x2009;+&#x2009;ATV/r-exposed mice had the lowest grooming times (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, difference in mean from control for male TDF/FTC&#x2009;+&#x2009;ATV/r&#x2009;&#x2212;&#x2009;14.5&#x2009;s, <italic>p</italic>&#x2009;=&#x2009;0.04, for female &#x2212;10.7&#x2009;s, <italic>p</italic>&#x2009;=&#x2009;0.02). The significant difference in the TDF/FTC&#x2009;+&#x2009;ATV/&#x2212;exposed males was lost when we adjusted for weight at postnatal day 3 (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table S2</xref>). As expected, we observed a strong correlation between rearing time and distance traveled (<italic>r</italic>&#x2009;=&#x2009;0.57, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.0001; <xref ref-type="fig" rid="fig2">Figure 2E</xref>). In support of increased grooming being an anxiety-related behavior, we observed a negative correlation between grooming time and distance traveled (<italic>r</italic>&#x2009;=&#x2009;&#x2212;0.44, <italic>p</italic> &#x003C;&#x2009;0.0001; <xref ref-type="fig" rid="fig2">Figure 2F</xref>).</p>
<p>Next, we used the zero maze and light/dark box, two tests of exploratory and avoidance-related behaviors that are more sensitive to anxiety-related behavior (<xref ref-type="bibr" rid="ref55">H&#x00E5;nell and Marklund, 2014</xref>; <xref ref-type="bibr" rid="ref118">Thompson et al., 2018</xref>; <xref ref-type="bibr" rid="ref68">La-Vu et al., 2020</xref>). Mice exposed to TDF/FTC&#x2009;+&#x2009;ATV/r spent more time in the light chamber of the light/dark chamber test, although this reached significance compared to controls only in the female mice (<xref ref-type="fig" rid="fig2">Figure 2G</xref>, difference in mean from control for male TDF/FTC&#x2009;+&#x2009;ATV/r&#x2009;+&#x2009;20.8&#x2009;s, <italic>p</italic>&#x2009;=&#x2009;0.18, for female +33.0&#x2009;s, <italic>p</italic>&#x2009;=&#x2009;0.002). As predicted, male and female mice exposed to TDF/FTC&#x2009;+&#x2009;ATV/r spent more time in the open area of the zero maze compared to controls although this only reached significance for male mice (<xref ref-type="fig" rid="fig2">Figure 2H</xref>, difference in mean from control for male TDF/FTC&#x2009;+&#x2009;ATV/r&#x2009;+&#x2009;21.1&#x2009;s, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001, for female +11.9&#x2009;s, <italic>p</italic>&#x2009;=&#x2009;0.11). Male mice exposed to ABC/3TC&#x2009;+&#x2009;ATV/r also spent significantly more time in the open area compared to controls (mean difference from control for male ABC/3TC&#x2009;+&#x2009;ATV/r&#x2009;+&#x2009;12.9&#x2009;s, <italic>p</italic>&#x2009;=&#x2009;0.036), although significance was lost when we adjusted for weight at postnatal day 3 (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table S2</xref>).</p>
<p>Collectively our data suggest increased mobility and exploratory behavior, as well as indications of reduced anxiety or increased risk-taking behavior, in mice exposed to TDF/FTC&#x2009;+&#x2009;ATV/r.</p>
</sec>
<sec id="sec16">
<label>3.2</label>
<title>Working memory and sociability is impaired in mice exposed <italic>in utero</italic> to ARV regimens</title>
<p>Deficits in cognitive abilities have been reported in CHEU as compared to unexposed children, including learning deficits and mild cognitive impairment (<xref ref-type="bibr" rid="ref127">Wedderburn et al., 2019a</xref>, <xref ref-type="bibr" rid="ref129">2022b</xref>; <xref ref-type="bibr" rid="ref133">Yao et al., 2023</xref>). We first assessed hippocampal-dependent working memory, requiring neural circuits associated with the prefrontal cortex and medial temporal lobe (<xref ref-type="bibr" rid="ref51">Frank et al., 2004</xref>; <xref ref-type="bibr" rid="ref28">Chao et al., 2022</xref>; <xref ref-type="bibr" rid="ref125">Voitov and Mrsic-Flogel, 2022</xref>). The novel object recognition test is a test of non-spatial, episodic memory that is independent of neuromotor deficits and emotional cues. A &#x201C;memory index&#x201D; was calculated as (T<sub>N</sub>-T<sub>F</sub>)/(T<sub>N</sub>&#x2009;+&#x2009;T<sub>F</sub>), wherein &#x201C;T<sub>N</sub>&#x201D; represents time exploring a novel object and &#x201C;T<sub>F</sub>&#x201D; the duration of familiar object exploration. A positive memory index indicates preference for the novel object, which is normal behavior for mice. As expected, the control mice spent statistically significantly more time exploring the novel object rather than the familiar object, with a mean memory index with SEM of 0.22&#x2009;&#x00B1;&#x2009;0.03 for males and 0.19&#x2009;&#x00B1;&#x2009;0.03 for females (<xref ref-type="table" rid="tab2">Table 2</xref>). The time spent exploring the novel object, as well as memory index, were lower in ABC/3TC&#x2009;+&#x2009;ATV/r treatment group compared to controls for both males and females (<xref ref-type="fig" rid="fig3">Figures 3A</xref>,<xref ref-type="fig" rid="fig3">B</xref>), with the memory index being close to zero indicating failure to differentiate between the novel and familiar object (memory index with SEM for ABC/3TC&#x2009;+&#x2009;ATV/r: 0.036&#x2009;&#x00B1;&#x2009;0.06 for male, &#x2212;0.0003&#x2009;&#x00B1;&#x2009;0.04 for female; <xref ref-type="table" rid="tab2">Table 2</xref>). While time spent exploring the novel object was similar between the TDF/FTC&#x2009;+&#x2009;ATV/r group and control, total exploration time was significantly higher in mice exposed to TDF/FTC&#x2009;+&#x2009;ATV/r, which supports the open field results of hyperactivity (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, difference in mean from control for male TDF/FTC&#x2009;+&#x2009;ATV/r&#x2009;+&#x2009;55.7&#x2009;s, <italic>p</italic>&#x2009;=&#x2009;0.001, for female +86.7&#x2009;s, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001). This also resulted in a lower memory index for both male and female mice exposed to TDF/FTC&#x2009;+&#x2009;ATV/r as compared to controls (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), with the memory index being 0.11&#x2009;&#x00B1;&#x2009;0.03 for males and 0.089&#x2009;&#x00B1;&#x2009;0.03 for female mice (<xref ref-type="table" rid="tab2">Table 2</xref>). These findings suggest an impairment in working/reference memory encoding in mice exposed to both regimens <italic>in utero</italic>.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Working memory and sociability is impaired in mice exposed <italic>in utero</italic> to ART. Difference in mean performance from control (indicated as the dotted line) with 95% confidence intervals are shown for male and female mice exposed to ABC/3TC&#x2009;+&#x2009;ATV/r (red dots) or TDF/FTC&#x2009;+&#x2009;ATV/r (blue dots) for the novel object recognition test <bold>(A&#x2013;C)</bold> and 3-chamber social test <bold>(D,E)</bold>. For the novel object recognition test we show difference in mean <bold>(A)</bold> time with the novel object, <bold>(B)</bold> memory index, and <bold>(C)</bold> exploration time. For the 3-chamber social approach test we show difference in mean <bold>(D)</bold> sociability index and <bold>(E)</bold> social novelty index. Mixed effects linear models with robust standard errors were fit to estimate the difference in mean performance, 95% confidence intervals, and p-values between ART-exposed mice and controls for each test metric. Litter was included as a random variable to account for litter variability. For males: <italic>n</italic>&#x2009;=&#x2009;21 from 6 litters for ABC/3TC&#x2009;+&#x2009;ATV/r, <italic>n</italic>&#x2009;=&#x2009;22 from 6 litters for TDF/FTC&#x2009;+&#x2009;ATV/r, and <italic>n</italic>&#x2009;=&#x2009;28 from 9 litters for control. For females: <italic>n</italic>&#x2009;=&#x2009;27 from 8 litters for ABC/3TC&#x2009;+&#x2009;ATV/r, <italic>n</italic> =&#x2009;21 from 6 litters for TDF/FTC&#x2009;+&#x2009;ATV/r, <italic>n</italic>&#x2009;=&#x2009;27 from 9 litters for control. &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001. ABC, abacavir; 3TC, lamivudine; TDF, tenofovir; FTC, emtricitabine; ATV/r. ritonavir-boosted atazanavir.</p>
</caption>
<graphic xlink:href="fnmol-17-1376681-g003.tif"/>
</fig>
<p>We next investigated social memory in our mouse model using 3-chambered social approach test. Mice exposed to TDF/FTC&#x2009;+&#x2009;ATV/r showed reduced performance (lower sociability index) in the first task of the test, although this only reached significance for the female mice (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, difference in mean from control for male TDF/FTC&#x2009;+&#x2009;ATV/r&#x2009;&#x2212;&#x2009;0.093, <italic>p</italic>&#x2009;=&#x2009;0.09, for female &#x2212;0.10, <italic>p</italic>&#x2009;=&#x2009;0.008). ABC/3TC&#x2009;+&#x2009;ATV/r exposed females showed reduced social novelty (lower social novelty index) in the second task (<xref ref-type="fig" rid="fig3">Figure 3E</xref>, difference in mean from control for male ABC/3TC&#x2009;+&#x2009;ATV/r&#x2009;&#x2212;&#x2009;0.037, <italic>p</italic>&#x2009;=&#x2009;0.56, for female &#x2212;0.18, <italic>p</italic>&#x2009;=&#x2009;0.005). Females exposed to TDF/FTC&#x2009;+&#x2009;ATV/r also had a lower social novelty index compared to controls although this did not reach significance (<italic>p</italic>&#x2009;=&#x2009;0.08). Our data suggest that female mice may be more susceptible to sociability deficits due to ART exposure and that NRTI backbone can also influence responses.</p>
</sec>
<sec id="sec17">
<label>3.3</label>
<title><italic>In utero</italic> exposure to ABC/3TC&#x2009;+&#x2009;ATV/r, but not TDF/FTC&#x2009;+&#x2009;ATV/r, leads to brain volumetric reductions that correlate with memory deficits</title>
<p>With deficits observed in learning and memory functions of the hippocampus, we next investigated the effect of <italic>in utero</italic> ART exposure on the macroscopic morphology of the brain using magnetic resonance imaging (MRI). At a false discovery rate of 1%, we observed statistically significant reductions in total brain volume in the ABC/3TC&#x2009;+&#x2009;ATV/r group compared to controls. The decrease in total brain volume was not uniform across the brain, with significant brain volume decreases observed primarily in the cortex and thalamus (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, center panel). When normalized to account for total brain volume, we also observed significant relative volume differences in brain regions of ABC/3TC&#x2009;+&#x2009;ATV/r exposed mice as compared to controls (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, right panel). Of interest areas associated with memory, including the hippocampus, were significantly smaller in the ABC/3TC&#x2009;+&#x2009;ATV/r exposed mice vs. control. No differences were observed in TDF/FTC&#x2009;+&#x2009;ATV/r treatment group compared to controls (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, left panel).</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p><italic>In utero</italic> exposure to ABC/3TC&#x2009;+&#x2009;ATV/r is associated with volumetric changes in the brain. <bold>(A)</bold> Magnetic resonance imaging of absolute and relative volumes in ABC/3TC&#x2009;+&#x2009;ATV/r and TDF/FTC&#x2009;+&#x2009;ATV/r exposed mice compared to controls (blue regions show decreased volume while red regions show increased volumes). Difference in mean relative volume compared to control for gray matter <bold>(B)</bold> and CA1 <bold>(C)</bold> for ABC/3TC&#x2009;+&#x2009;ATV/r (red dots) or TDF/FTC&#x2009;+&#x2009;ATV/r (blue dots) exposed mice. <bold>(D&#x2013;F)</bold> Correlation between CA1 relative volume and memory index (novel object recognition test) in controls <bold>(D)</bold>, ABC/3TC&#x2009;+&#x2009;ATV/r exposed mice <bold>(E)</bold>, and TDF/FTC&#x2009;+&#x2009;ATV/r exposed mice <bold>(F)</bold>. Mixed effects linear models with robust standard errors were fit to estimate the difference in mean volume, 95% confidence intervals, and p-values between ART-exposed mice and controls. Litter was included as a random variable to account for litter variability. Correlations by Pearson r. For control, <italic>n</italic>&#x2009;=&#x2009;24 (11 male, 13 females) from 8 litters; for ABC/3TC&#x2009;+&#x2009;ATV/r, <italic>n</italic>&#x2009;=&#x2009;14 (7 male, 7 female) from 6 litters; for TDF/FTC&#x2009;+&#x2009;ATV/r, <italic>n</italic>&#x2009;=&#x2009;15 (8 male, 7 female) from 5 litters. &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001. ABC, abacavir; 3TC, lamivudine; TDF, tenofovir; FTC, emtricitabine; ATV/r. ritonavir-boosted atazanavir.</p>
</caption>
<graphic xlink:href="fnmol-17-1376681-g004.tif"/>
</fig>
<p>When further dissected into regions, ABC/3TC&#x2009;+&#x2009;ATV/r exposed mice showed significantly lower gray matter volume as compared to controls and TDF/FTC&#x2009;+&#x2009;ATV/r exposed mice (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, difference in mean from control -17&#x2009;mm<sup>3</sup>, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.0001). The volume of the CA1 region of the hippocampus was also lower in ABC/3TC&#x2009;+&#x2009;ATV/r exposed mice as compared to controls (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, difference in mean from control &#x2212;0.0004mm<sup>3</sup>, <italic>p</italic> &#x003C;&#x2009;0.0001). Since there were no significant sex-by-group interactions, for these analyses we combined males and females. We observed a strong positive correlation between CA1 volume and memory index in ABC/3TC&#x2009;+&#x2009;ATV/r exposed mice, but not in the control or TDF/FTC&#x2009;+&#x2009;ATV/r exposed mice (<xref ref-type="fig" rid="fig4">Figures 4D</xref>&#x2013;<xref ref-type="fig" rid="fig4">F</xref>).</p>
<p>Supporting the MRI findings of smaller hippocampal volume, immunostaining of paraffin-embedded fixed sections of the brain with the neuronal marker NeuN, showed a decreased count of pyramidal neurons in the CA1 and dentate gyrus granule cells of ABC/3TC&#x2009;+&#x2009;ATV/r exposed mice compared to controls (<xref ref-type="fig" rid="fig5">Figures 5A</xref>&#x2013;<xref ref-type="fig" rid="fig5">C</xref>). We also investigated changes in the number of glial cells using glial fibrillary acidic protein (GFAP) as a marker, but observed no differences between treatment groups (<xref ref-type="fig" rid="fig5">Figures 5D</xref>,<xref ref-type="fig" rid="fig5">E</xref>). These results support an association between brain volumetric reductions, reduced neuronal counts, and memory deficit in mice exposed to ABC/3TC&#x2009;+&#x2009;ATV/r. In contrast TDF/FTC&#x2009;+&#x2009;ATV/r exposure was not associated with macroscopic brain volumetric differences.</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>Neuronal, but not glial, populations in CA1 and dentate gyrus of the hippocampus are reduced in ABC/3TC&#x2009;+&#x2009;ATV/r mice. <bold>(A&#x2013;E)</bold> Representative immunofluorescence images of CA1 region of ABC/3TC&#x2009;+&#x2009;ATV/r and control mice stained with NeuN (red), GFAP (green) and DAPI (blue). Number of neurons (NeuN+ cells) in CA1 <bold>(B)</bold> and dentate gyrus <bold>(C)</bold> of the hippocampus. Number of glial cells (GFAP+) in CA1 <bold>(D)</bold> and dentate gyrus <bold>(E)</bold> of the hippocampus. Data are shown as violin plots with dots indicating counts for each mouse and line indicating mean. Statistical comparisons using Student&#x2019;s t-test; &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05. <italic>N</italic>&#x2009;=&#x2009;10 (5 male, 5 female) per treatment group. Scale bar is 50&#x2009;&#x03BC;m. ABC, abacavir; 3TC, lamivudine; TDF, tenofovir; FTC, emtricitabine; ATV/r. ritonavir-boosted atazanavir.</p>
</caption>
<graphic xlink:href="fnmol-17-1376681-g005.tif"/>
</fig>
</sec>
<sec id="sec18">
<label>3.4</label>
<title>Altered gene expression in the hippocampus of mice exposed i<italic>n utero</italic> to ABC/3TC&#x2009;+&#x2009;ATV/r and TDF&#x2009;+&#x2009;FTC/ATV/r</title>
<p>We next investigated if there are molecular changes in the brain that could underly the observed behavior phenotypes in our model. Experience-dependent modification of neural circuits occurs through changes in synaptic transmission and synaptic plasticity (<xref ref-type="bibr" rid="ref79">Malenka, 2003</xref>; <xref ref-type="bibr" rid="ref89">Nicoll, 2003</xref>; <xref ref-type="bibr" rid="ref31">Citri and Malenka, 2008</xref>; <xref ref-type="bibr" rid="ref117">S&#x00FC;dhof and Malenka, 2008</xref>). Two glutamate neurotransmitter receptors that drive synaptic plasticity in the hippocampus of the mammalian brain are amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) and N-methyl-D-aspartate receptor (NMDAR; <xref ref-type="bibr" rid="ref76">L&#x00FC;scher and Malenka, 2012</xref>; <xref ref-type="bibr" rid="ref94">Penn et al., 2017</xref>). Further, postsynaptic density protein-95 (PSD95) is a major regulator of synaptic maturation by interacting, stabilizing, and trafficking NMDARs and AMPARs to the postsynaptic membrane in the neurons (<xref ref-type="bibr" rid="ref66">Kornau et al., 1995</xref>; <xref ref-type="bibr" rid="ref44">Schnell et al., 2002</xref>). <italic>In utero</italic> exposure to ART led to deficits in hippocampal-dependent working memory in our mouse model and increased exploration. Thus, we investigated changes in gene expression of major neurotransmitter receptors affecting memory encoding in the hippocampus. We identified lower mRNA expression of AMPAR subunits GluA1 and GluA2 (<xref ref-type="fig" rid="fig6">Figures 6A</xref>,<xref ref-type="fig" rid="fig6">B</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary Table S1</xref>) in TDF/FTC&#x2009;+&#x2009;ATV/r exposed females and males, respectively. In contrast, we observed lower mRNA expression of the NMDAR subunits GluN2A and GluN2B in ABC/3TC&#x2009;+&#x2009;ATV/r exposed females (<xref ref-type="fig" rid="fig6">Figures 6C</xref>,<xref ref-type="fig" rid="fig6">D</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary Table S1</xref>). Lower mRNA expression levels of the postsynaptic scaffolding protein PSD95 were also observed in ABC/3TC&#x2009;+&#x2009;ATV/r exposed females compared to controls (<xref ref-type="fig" rid="fig6">Figure 6E</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary Table S1</xref>).</p>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p>Altered gene expression in the hippocampus of mice exposed to ABC/3TC&#x2009;+&#x2009;ATV/r and TDF&#x2009;+&#x2009;FTC/ATV/r <italic>in utero</italic>. Difference in mean hippocampal gene expression (arbitrary units) from control (indicated as the dotted line) with 95% confidence intervals are shown for male and female mice exposed to ABC/3TC&#x2009;+&#x2009;ATV/r (red dots) or TDF/FTC&#x2009;+&#x2009;ATV/r (blue dots) for GluA1 <bold>(A)</bold>, GluA2 <bold>(B)</bold>, GluN2A <bold>(C)</bold>, GluN2B <bold>(D)</bold>, PSD95 <bold>(E)</bold>, BDNF <bold>(F)</bold>, TrkB-full length receptor <bold>(G)</bold>, TrkB-truncated receptor <bold>(H)</bold>. Mixed effects linear models with robust standard errors were fit to estimate the difference in mean expression, 95% confidence intervals, and <italic>p</italic>-values between ART-exposed mice and controls. Litter was included as a random variable to account for litter variability. For control, <italic>n</italic>&#x2009;=&#x2009;20 (11 male, 9 female) from 11 litters; for ABC/3TC&#x2009;+&#x2009;ATV/r, <italic>n</italic>&#x2009;=&#x2009;25 (11 male, 14 female) from 12 litters; for TDF/FTC&#x2009;+&#x2009;ATV/r, n&#x2009;=&#x2009;25 (12 male, 13 female) from 11 litters. &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001. ABC, abacavir; 3TC, lamivudine; TDF, tenofovir; FTC, emtricitabine; ATV/r. ritonavir-boosted atazanavir.</p>
</caption>
<graphic xlink:href="fnmol-17-1376681-g006.tif"/>
</fig>
<p>Next, we assessed potential neurotrophic factors that are associated with modulation of neurotransmitter receptors. Several studies have reported the role of neurotrophic signaling of brain-derived neurotrophic factor (BDNF) and its downstream modulatory effect on the expression of AMPARs (<xref ref-type="bibr" rid="ref82">Martinez-Turrillas et al., 2002</xref>; <xref ref-type="bibr" rid="ref81">Mart&#x00ED;nez-Turrillas et al., 2005</xref>; <xref ref-type="bibr" rid="ref59">Jourdi et al., 2009</xref>; <xref ref-type="bibr" rid="ref8">Autry and Monteggia, 2012</xref>; <xref ref-type="bibr" rid="ref63">Keifer, 2022</xref>; <xref ref-type="bibr" rid="ref54">Gliwi&#x0144;ska et al., 2023</xref>). Not only does BDNF signaling promote the formation of new synapses and exert an effect on the pre-synapse, but it also plays a role in promoting synaptic plasticity in the post-synapse (<xref ref-type="bibr" rid="ref59">Jourdi et al., 2009</xref>; <xref ref-type="bibr" rid="ref8">Autry and Monteggia, 2012</xref>; <xref ref-type="bibr" rid="ref40">Diering and Huganir, 2018</xref>; <xref ref-type="bibr" rid="ref93">Park, 2018</xref>). Given the role of BDNF signaling in the brain, we assessed the expression of BDNF and its receptors, tyrosine kinase B (TrkB) full-length and TrkB truncated in the hippocampus. We observed statistically significantly higher mRNA levels of BDNF in ABC/3TC&#x2009;+&#x2009;ATV/r exposed males (<xref ref-type="fig" rid="fig6">Figure 6F</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary Table S1</xref>). Further, we observed lower mRNA levels of the BDNF receptors TrkB full-length (both males and females) and TrkB truncated (males only) in TDF/FTC&#x2009;+&#x2009;ATV/r exposed mice compared to controls (<xref ref-type="fig" rid="fig6">Figures 6G</xref>,<xref ref-type="fig" rid="fig6">H</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary Table S1</xref>). In contrast, we found upregulation of the TrkB truncated in ABC/3TC&#x2009;+&#x2009;ATV/r exposed females (<xref ref-type="fig" rid="fig6">Figure 6H</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary Table S1</xref>). Thus, our findings suggest that <italic>in utero</italic> exposure to ART regimes can lead to an alteration in the receptors associated with synaptic plasticity and neuromodulator proteins in the hippocampal region of the brain.</p>
</sec>
</sec>
<sec sec-type="discussion" id="sec19">
<label>4</label>
<title>Discussion</title>
<p>Using a pregnant mouse model, we demonstrated that <italic>in utero</italic> exposure to ART regimens that contained atazanavir (protease inhibitor) with two different NRTI backbones are associated with long-term adverse neurodevelopmental outcomes in progeny adult mice. Our investigation led us to the following conclusions: <italic>In utero</italic> exposure to ART that contained the NRTI backbone TDF/FTC was associated with increased risk-taking and exploratory behavior in the open field maze, zero maze and light/dark box. Exposure to ART that contained ABC/3TC or TDF/FTC led to impairments in working memory. Volumetric reductions and morphological changes in gray matter were observed in mice that were exposed to ART that contained ABC/3TC, including the hippocampus. Gene expression analysis of the hippocampus showed changes in neurotransmitter receptor composition and alterations in proteins that are involved in transmission and neurotrophic signaling in the brain of mice exposed to both ART regimens.</p>
<p>Differences in the NRTI backbone are often not considered in neurodevelopmental studies, but our findings suggest that the NRTI backbone can influence neurocognitive outcomes. We observed a stark contrast between the two different NRTI backbones tested and the neurodevelopmental outcomes observed. Mice exposed to TDF/FTC showed enhanced exploratory drive and decreased anxiety as observed by increased total distance traveled, mobile time, and rearing in the open field test, increased time spent in the open area of the zero maze test, increased duration in the light chamber of light/dark box test, and increased exploration in the novel object recognition test. Mice exposed to ABC/3TC showed increased grooming reminiscent of anxiety-like behavior, although we did not observe any increased anxious behavior in other tests. Both regimens were associated with statistically significant deficits in working memory. Sociability/social novelty deficits were observed with both regimens but primarily in female mice. Additionally, ABC/3TC-exposed mice had statistically significant brain volumetric and morphological deficits when compared to control mice, while mice exposed to TDF/FTC did not. Our data support the inclusion of not only class-based but also individual drug-based investigations in future studies, and additional considerations on the NRTIs used within each ART regimen.</p>
<p>Adverse motor outcomes, gross motor delays, as well as hyperkinetic syndrome have been observed in CHEU (<xref ref-type="bibr" rid="ref107">Sanmaneechai et al., 2005</xref>; <xref ref-type="bibr" rid="ref122">Van Rie et al., 2008</xref>; <xref ref-type="bibr" rid="ref18">Budd et al., 2018</xref>; <xref ref-type="bibr" rid="ref70">Le Roux et al., 2018</xref>; <xref ref-type="bibr" rid="ref95">Piske et al., 2018</xref>; <xref ref-type="bibr" rid="ref130">Wedderburn et al., 2019b</xref>), although associations with specific ARV exposures is difficult to surmise given the multiple exposures and confounding factors that can influence outcomes and are difficult to control. The combined phenotype of increased exploration and risk-taking behavior, and sociability deficits seen in mice exposed to TDF/FTC&#x2009;+&#x2009;ATV/r in our study is reminiscent of attention-deficit-hyperactive disorder (ADHD). Higher rates of ADHD have been reported in CHEU that correlated with deficits in executive function (<xref ref-type="bibr" rid="ref20">Burkey et al., 2015</xref>).</p>
<p><italic>In utero</italic> exposure to either NRTI backbone in the presence of ATV/r resulted in deficits of hippocampal-dependent memories, with both regimens being associated with lower memory index in the novel object recognition test as compared to controls. Our results support previous studies investigating the impact of NRTI exposure on cognitive and learning tasks in rodents (<xref ref-type="bibr" rid="ref83">McHenry et al., 2019</xref>). Deficits in spatial and working memory tests using Morris water maze were observed in rats treated with ART containing TDF/3TC and the non-nucleoside reverse transcriptase inhibitor (NNRTI), efavirenz (<xref ref-type="bibr" rid="ref5">Akang, 2019</xref>). Similar to our findings, mice perinatally exposed to either monotherapy or dual therapy with zidovudine and 3TC showed a trend of delayed acquisition and retention of trials in passive avoidance tests (<xref ref-type="bibr" rid="ref23">Calamandrei et al., 1999a</xref>,<xref ref-type="bibr" rid="ref25">b</xref>; <xref ref-type="bibr" rid="ref124">Venerosi et al., 2001</xref>). However, no negative impact on working or reference memory was observed in CD-1 mice perinatally exposed to 3TC monotherapy (<xref ref-type="bibr" rid="ref24">Calamandrei et al., 2000</xref>; <xref ref-type="bibr" rid="ref83">McHenry et al., 2019</xref>). Deficits in learning and acquisition have also been reported in CHEU exposed to protease inhibitor and NRTI-containing regimens, including working memory deficits, lower verbal retention scores, and executive memory function deficits, and may contribute to the higher frequency of reading and math impairments observed in school age CHEU (<xref ref-type="bibr" rid="ref29">Chase et al., 2000</xref>; <xref ref-type="bibr" rid="ref92">Nozyce et al., 2014</xref>; <xref ref-type="bibr" rid="ref26">Caniglia et al., 2016</xref>; <xref ref-type="bibr" rid="ref111">Sirois et al., 2016</xref>; <xref ref-type="bibr" rid="ref87">Milligan and Cockcroft, 2017</xref>; <xref ref-type="bibr" rid="ref100">Rice et al., 2018</xref>; <xref ref-type="bibr" rid="ref32">Cockcroft and Milligan, 2019</xref>; <xref ref-type="bibr" rid="ref134">Young et al., 2021</xref>; <xref ref-type="bibr" rid="ref129">Wedderburn et al., 2022b</xref>).</p>
<p>Our findings also showed a small but significant deficit in sociability tasks with both ART regimens, with more pronounced effects seen in female mice. Difficulty in social settings and social neurodevelopment have been strongly reported in CHEU, including lower sociability scores compared to HIV unexposed children (<xref ref-type="bibr" rid="ref99">Rencken et al., 2022</xref>), and poorer academic performances due to communication issues and social interaction with peers in school settings (<xref ref-type="bibr" rid="ref127">Wedderburn et al., 2019a</xref>,<xref ref-type="bibr" rid="ref130">b</xref>; <xref ref-type="bibr" rid="ref77">Madlala et al., 2020</xref>; <xref ref-type="bibr" rid="ref99">Rencken et al., 2022</xref>; <xref ref-type="bibr" rid="ref86">Mensi et al., 2023</xref>). This is the first study that reports social deficits in mice perinatally exposed to clinically relevant doses of combination ART, although sex-specific changes in social behavior were reported in CD-1 mice perinatally exposed to AZT (<xref ref-type="bibr" rid="ref123">Venerosi et al., 2003</xref>). Our data suggest that ARV exposure may contribute in part to sociability deficits, and support the inclusion of sex as a variable in sociability studies of CHEU.</p>
<p>To begin to understand the mechanisms that could underly the deficits observed in our study we examined brain volumetric reductions, as well as hippocampal gene expression profiles of neurotransmitter receptors and neurotrophic factors that play a central role in neurophysiology of the observed deficits (<xref ref-type="bibr" rid="ref126">Wang, 1999</xref>; <xref ref-type="bibr" rid="ref88">Newcomer and Krystal, 2001</xref>; <xref ref-type="bibr" rid="ref71">Lee and Kesner, 2002</xref>; <xref ref-type="bibr" rid="ref106">Sanderson et al., 2008</xref>; <xref ref-type="bibr" rid="ref10">Baddeley et al., 2011</xref>; <xref ref-type="bibr" rid="ref105">Sanderson and Bannerman, 2012</xref>; <xref ref-type="bibr" rid="ref2">Abad-Perez et al., 2023</xref>). Mice exposed to ABC/3TC&#x2009;+&#x2009;ATV/r, but not those exposed to TDF/FTC&#x2009;+&#x2009;ATV/r, had significant reduced volume in several brain regions compared to controls, primarily in the gray matter within the striatum, medulla, midbrain, temporal lobe, entorhinal cortex, lateral septum, and hippocampus. Similar changes in brain volume have been observed in CHEU, including reduction in gray matter, as compared to unexposed children that correlated to poorer maternal immune status (<xref ref-type="bibr" rid="ref128">Wedderburn et al., 2022a</xref>). Our data suggest that, in addition to HIV and maternal immune status, ARV exposure may also play a role in brain volumetric changes in CHEU, and that gray matter may be more susceptible to NRTI exposure. Our observations that neuroanatomical volumetric alterations were observed in only the ABC/3TC-containing ATV/r-based regimen, and the absence of significant changes in the TDF/FTC&#x2009;+&#x2009;ATV/r-exposed mice, suggest an NRTI effect on brain volume, as well as differential responses to different NRTIs. It is possible that poor penetration of protease inhibitors across the placenta and blood&#x2013;brain barriers may limit their effects on fetal brain development. In contrast NRTIs can pass freely through such barriers. In fact, ABC and 3TC, but not ATV/r, were detectable in fetal brains of mice exposed <italic>in utero</italic> to ABC/3TC-ATV/r (<xref ref-type="bibr" rid="ref53">Gilmore et al., 2021</xref>).</p>
<p>The reductions in hippocampal volume we observed in ABC/3TC-exposed mice may be attributable to neuronal loss. We observed lower neuronal numbers, but not glial cells, in the hippocampus of ABC/3TC-exposed mice. The hippocampus is one of the brain regions affected in the context of fetal growth restriction or prenatal compromise, leading to neuronal loss and reduced volumes, as well as abnormal neuronal function in the spared neurons (<xref ref-type="bibr" rid="ref80">Mallard et al., 2000</xref>; <xref ref-type="bibr" rid="ref39">Dieni and Rees, 2003</xref>; <xref ref-type="bibr" rid="ref57">Illa et al., 2013</xref>; <xref ref-type="bibr" rid="ref12">Basilious et al., 2015</xref>). Increased neurodegeneration, including shrinkage of cytoplasm and pyknotic nuclei in CA1 and dentate gyrus, has been reported in Wistar rats exposed to TDF/3TC and efavirenz (<xref ref-type="bibr" rid="ref5">Akang, 2019</xref>). Multiple <italic>in vitro</italic> studies report oxidative and mitochondrial stress, neurotoxicity and astrocyte senescence in cultured neurons and astrocytes exposed to monotherapy or combined antiretroviral therapy (<xref ref-type="bibr" rid="ref45">Ellis et al., 2007</xref>; <xref ref-type="bibr" rid="ref72">Liner et al., 2010</xref>; <xref ref-type="bibr" rid="ref102">Robertson et al., 2012</xref>; <xref ref-type="bibr" rid="ref6">Akay et al., 2014</xref>; <xref ref-type="bibr" rid="ref15">Blas-Garc&#x00ED;a et al., 2014</xref>; <xref ref-type="bibr" rid="ref109">Shah et al., 2016</xref>; <xref ref-type="bibr" rid="ref33">Cohen et al., 2017</xref>; <xref ref-type="bibr" rid="ref91">Nooka and Ghorpade, 2017</xref>; <xref ref-type="bibr" rid="ref104">Sanchez and Kaul, 2017</xref>; <xref ref-type="bibr" rid="ref35">De Benedetto et al., 2020</xref>; <xref ref-type="bibr" rid="ref13">Bertrand et al., 2021</xref>; <xref ref-type="bibr" rid="ref67">Lanman et al., 2021</xref>; <xref ref-type="bibr" rid="ref50">Foster et al., 2022</xref>; <xref ref-type="bibr" rid="ref103">Rudd and Toborek, 2022</xref>). While these studies investigated the direct neurotoxic effects of ARVs, our mice were only exposed to ARVs <italic>in utero</italic>. Our findings suggest that ARV-associated neurotoxic effects experienced <italic>in utero</italic> can result in long-term consequences on brain morphology.</p>
<p>We observed a direct correlation between hippocampal CA1 volume and memory index in the ABC/3TC-exposed mice. Previous studies have reported an association between reduction in neuronal and astrocyte numbers in the hippocampus and impairments in hippocampal-dependent learning (<xref ref-type="bibr" rid="ref49">Fitting et al., 2008</xref>; <xref ref-type="bibr" rid="ref5">Akang, 2019</xref>); as encoding episodic memories requires the transmission of signals from granule cells of the dentate gyrus and CA1 pyramidal neurons in the hippocampus (<xref ref-type="bibr" rid="ref64">Kitamura et al., 2015</xref>, <xref ref-type="bibr" rid="ref65">2017</xref>). However, the memory deficit observed in the TDF/FTC&#x2009;+&#x2009;ATV/r-exposed mice cannot be attributed to volumetric alterations in the brain, as we did not observe any volumetric differences in the brains of TDF/FTC&#x2009;+&#x2009;ATV/r-exposed mice compared to controls. Therefore, other pathways, such as neurotrophins and neurotransmitters could be involved. We observed downregulation of major glutamate receptors, AMPAR and NMDAR, in the hippocampus that may suggest an imbalance between inhibition/excitation in neural circuits that govern working memory and sociability in ART-exposed mice. Hyper-exploration also requires neurocircuitry involving the hippocampus (<xref ref-type="bibr" rid="ref121">Van Praag et al., 1994</xref>), as well as the prefrontal cortex, and motor cortex (<xref ref-type="bibr" rid="ref58">Johnson et al., 2012</xref>; <xref ref-type="bibr" rid="ref41">Dong et al., 2021</xref>). Alteration in hippocampal mechanisms that govern oscillatory activity (rhythmic patterns of neural activity), which is regulated by AMPAR and NMDAR, can lead to altered exploratory activity and locomotion in rodents (<xref ref-type="bibr" rid="ref21">Buzs&#x00E1;ki, 2002</xref>; <xref ref-type="bibr" rid="ref98">R&#x00E1;cz et al., 2009</xref>; <xref ref-type="bibr" rid="ref7">Akg&#x00FC;l and McBain, 2020</xref>). We also observed lower TrkB full-length levels in the hippocampus of TDF/FTC&#x2009;+&#x2009;ATV/r exposed mice, that could indicate that BDNF-dependent memory and locomotory pathways may be affected in these mice (<xref ref-type="bibr" rid="ref132">Yamada and Nabeshima, 2004</xref>; <xref ref-type="bibr" rid="ref74">Liu et al., 2015</xref>).</p>
<p>The focus of the current study was to understand the long-term deficits caused by <italic>in utero</italic> ART exposure on the development of the brain and related behavioral outcomes, as perinatal insults during critical periods of brain development can lead to long-lasting behavioral changes in adults and these changes may not be apparent until maturity (<xref ref-type="bibr" rid="ref14">Black et al., 2017</xref>). Using a rodent model allowed us to focus on the impact of ART on the mechanisms of neurodevelopmental outcomes seen in CHEU without confounding factors such as HIV infection, and maternal, socioeconomic, and environmental factors (<xref ref-type="bibr" rid="ref127">Wedderburn et al., 2019a</xref>; <xref ref-type="bibr" rid="ref19">Bulterys et al., 2023</xref>). Our study identified neurophysiological deficits caused by <italic>in utero</italic> ART exposure in mice that can be correlated with the learning and cognitive delays, as well as attention deficits observed in CHEU (<xref ref-type="bibr" rid="ref20">Burkey et al., 2015</xref>). However, our study has limitations. Our model does not include perinatal HIV exposure. While this is a limitation, as it does not directly mimic the CHEU exposures, it does allow us to study the specific effects of ARVs without the confounding of the virus effects on neurodevelopment. Additionally, CHEU often receive ARVs after birth as part of HIV prophylaxis, but our pups were not dosed postnatally. This likely also underestimates the ARV impact on brain development in our model, as some of the brain development that happens <italic>in utero</italic> for humans, happens postnatally in mice. Our expression analyses are limited to the hippocampus, and do not explore other brain regions that may also be implicated in the behavioral phenotypes we observed. Further, we only quantified mRNA levels. Additional studies looking at protein levels and localization would further our understanding.</p>
<p>In conclusion, we present evidence that perinatal exposure to ARVs is associated with long-term neurodevelopmental outcomes, including memory deficits, sex-dependent sociability deficits, increased exploration, and heightened locomotory activity. Such deficits may underlie some of the learning and motor difficulties observed in school aged CHEU. Further, we observed dramatic differences between the two different NRTI backbones tested, with brain volumetric reductions seen with ABC/3TC exposure, and hyperactivity seen with TDF/FTC exposure. Our findings underscore the importance of longitudinal follow-up of CHEU, inclusion of sex in all analyses, and more detailed evaluation of the effects of exposure to the different components of ART, with the goal of optimizing HIV treatment in pregnancy and health outcomes for CHEU.</p>
</sec>
<sec sec-type="data-availability" id="sec20">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="sec21">
<title>Ethics statement</title>
<p>The animal study was approved by University Health Network Animal Use Committee. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="sec22">
<title>Author contributions</title>
<p>SHD: Formal analysis, Investigation, Writing &#x2013; original draft. KB: Formal analysis, Investigation, Writing &#x2013; original draft. AS: Investigation, Writing &#x2013; review &#x0026; editing. SA: Investigation, Writing &#x2013; review &#x0026; editing. HTJM: Conceptualization, Writing &#x2013; review &#x0026; editing. LSC: Formal analysis, Investigation, Writing &#x2013; review &#x0026; editing. JGS: Conceptualization, Formal analysis, Writing &#x2013; review &#x0026; editing. LS: Conceptualization, Data curation, Formal analysis, Funding acquisition, Supervision, Writing &#x2013; original draft.</p>
</sec>
</body>
<back>
<sec sec-type="funding-information" id="sec23">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work is funded by Canadian Institutes of Health Research (CIHR) grant #HAL 157984 (LS), and CANFAR grant #27010 (LS). LS is supported by a Tier 1 Canada Research Chair in Maternal-Child Health and HIV. SHD is supported by a CIHR Postdoctoral Fellowship. KB was supported by a CTN Postdoctoral Fellowship.</p>
</sec>
<ack>
<p>We would like to thank Monica S. Guzman Lenis for her contribution to this study.</p>
</ack>
<sec sec-type="COI-statement" id="sec24">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec25">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fnmol.2024.1376681/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fnmol.2024.1376681/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.pdf" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<fn-group>
<fn id="fn0001"><p><sup>1</sup><ext-link xlink:href="http://www.r-project.org" ext-link-type="uri">www.r-project.org</ext-link></p></fn>
<fn id="fn0002"><p><sup>2</sup><ext-link xlink:href="https://github.com/Mouse-Imaging-Centre/RMINC/" ext-link-type="uri">https://github.com/Mouse-Imaging-Centre/RMINC/</ext-link></p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abad-Perez</surname> <given-names>P.</given-names></name> <name><surname>Molina-Pay&#x00E1;</surname> <given-names>F. J.</given-names></name> <name><surname>Mart&#x00ED;nez-Otero</surname> <given-names>L.</given-names></name> <name><surname>Borrell</surname> <given-names>V.</given-names></name> <name><surname>Redondo</surname> <given-names>R. L.</given-names></name> <name><surname>Brotons-Mas</surname> <given-names>J. R.</given-names></name></person-group> (<year>2023</year>). <article-title>Theta/gamma co-modulation disruption after NMDAr blockade by MK-801 is associated with spatial working memory deficits in mice</article-title>. <source>Neuroscience</source> <volume>519</volume>, <fpage>162</fpage>&#x2013;<lpage>176</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroscience.2023.03.022</pub-id>, PMID: <pub-id pub-id-type="pmid">36990270</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Afran</surname> <given-names>L.</given-names></name> <name><surname>Garcia Knight</surname> <given-names>M.</given-names></name> <name><surname>Nduati</surname> <given-names>E.</given-names></name> <name><surname>Urban</surname> <given-names>B. C.</given-names></name> <name><surname>Heyderman</surname> <given-names>R. S.</given-names></name> <name><surname>Rowland-Jones</surname> <given-names>S. L.</given-names></name></person-group> (<year>2014</year>). <article-title>HIV-exposed uninfected children: a growing population with a vulnerable immune system?</article-title> <source>Clin. Exp. Immunol.</source> <volume>176</volume>, <fpage>11</fpage>&#x2013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1111/cei.12251</pub-id>, PMID: <pub-id pub-id-type="pmid">24325737</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="other"><person-group person-group-type="author"><collab id="coll2">AIDSinfo | UNAIDS</collab></person-group>. (<year>2024</year>) [cited 2024 Jan 10]. Available at: <ext-link xlink:href="https://aidsinfo.unaids.org/" ext-link-type="uri">https://aidsinfo.unaids.org/</ext-link></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akang</surname> <given-names>E. N.</given-names></name></person-group> (<year>2019</year>). <article-title>Combination antiretroviral therapy (cART)-induced hippocampal disorders: highlights on therapeutic potential of Naringenin and quercetin</article-title>. <source>IBRO Rep.</source> <volume>6</volume>, <fpage>137</fpage>&#x2013;<lpage>146</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ibror.2019.04.002</pub-id>, PMID: <pub-id pub-id-type="pmid">31061913</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akay</surname> <given-names>C.</given-names></name> <name><surname>Cooper</surname> <given-names>M.</given-names></name> <name><surname>Odeleye</surname> <given-names>A.</given-names></name> <name><surname>Jensen</surname> <given-names>B. K.</given-names></name> <name><surname>White</surname> <given-names>M. G.</given-names></name> <name><surname>Vassoler</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system</article-title>. <source>J. Neuro-Oncol.</source> <volume>20</volume>, <fpage>39</fpage>&#x2013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s13365-013-0227-1</pub-id>, PMID: <pub-id pub-id-type="pmid">24420448</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akg&#x00FC;l</surname> <given-names>G.</given-names></name> <name><surname>McBain</surname> <given-names>C. J.</given-names></name></person-group> (<year>2020</year>). <article-title>AMPA receptor deletion in developing MGE-derived hippocampal interneurons causes a redistribution of excitatory synapses and attenuates postnatal network oscillatory activity</article-title>. <source>Sci. Rep.</source> <volume>10</volume>, <fpage>1</fpage>&#x2013;<lpage>12</lpage>.</citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Autry</surname> <given-names>A. E.</given-names></name> <name><surname>Monteggia</surname> <given-names>L. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Brain-derived neurotrophic factor and neuropsychiatric disorders</article-title>. <source>Pharmacol. Rev.</source> <volume>64</volume>, <fpage>238</fpage>&#x2013;<lpage>258</lpage>. doi: <pub-id pub-id-type="doi">10.1124/pr.111.005108</pub-id>, PMID: <pub-id pub-id-type="pmid">22407616</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Avants</surname> <given-names>B. B.</given-names></name> <name><surname>Epstein</surname> <given-names>C. L.</given-names></name> <name><surname>Grossman</surname> <given-names>M.</given-names></name> <name><surname>Gee</surname> <given-names>J. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain</article-title>. <source>Med. Image Anal.</source> <volume>12</volume>, <fpage>26</fpage>&#x2013;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.media.2007.06.004</pub-id>, PMID: <pub-id pub-id-type="pmid">17659998</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baddeley</surname> <given-names>A.</given-names></name> <name><surname>Jarrold</surname> <given-names>C.</given-names></name> <name><surname>Vargha-Khadem</surname> <given-names>F.</given-names></name></person-group> (<year>2011</year>). <article-title>Working memory and the hippocampus</article-title>. <source>J. Cogn. Neurosci.</source> <volume>23</volume>, <fpage>3855</fpage>&#x2013;<lpage>3861</lpage>. doi: <pub-id pub-id-type="doi">10.1162/jocn_a_00066</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balogun</surname> <given-names>K.</given-names></name> <name><surname>Serghides</surname> <given-names>L.</given-names></name></person-group> (<year>2022</year>). <article-title>Comparison of the effects of three dual-Nucleos(t) ide reverse transcriptase inhibitor backbones on placenta mitochondria toxicity and oxidative stress using a mouse pregnancy model</article-title>. <source>Pharmaceutics.</source> <volume>14</volume>:<fpage>1063</fpage>. doi: <pub-id pub-id-type="doi">10.3390/pharmaceutics14051063</pub-id>, PMID: <pub-id pub-id-type="pmid">35631648</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Basilious</surname> <given-names>A.</given-names></name> <name><surname>Yager</surname> <given-names>J.</given-names></name> <name><surname>Fehlings</surname> <given-names>M. G.</given-names></name></person-group> (<year>2015</year>). <article-title>Neurological outcomes of animal models of uterine artery ligation and relevance to human intrauterine growth restriction: a systematic review</article-title>. <source>Dev. Med. Child Neurol.</source> <volume>57</volume>, <fpage>420</fpage>&#x2013;<lpage>430</lpage>. doi: <pub-id pub-id-type="doi">10.1111/dmcn.12599</pub-id>, PMID: <pub-id pub-id-type="pmid">25330710</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bertrand</surname> <given-names>L.</given-names></name> <name><surname>Velichkovska</surname> <given-names>M.</given-names></name> <name><surname>Toborek</surname> <given-names>M.</given-names></name></person-group> (<year>2021</year>). <article-title>Cerebral vascular toxicity of antiretroviral therapy</article-title>. <source>J. Neuroimmune Pharmacol.</source> <volume>16</volume>, <fpage>74</fpage>&#x2013;<lpage>89</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11481-019-09858-x</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Black</surname> <given-names>M. M.</given-names></name> <name><surname>Walker</surname> <given-names>S. P.</given-names></name> <name><surname>Fernald</surname> <given-names>L. C. H.</given-names></name> <name><surname>Andersen</surname> <given-names>C. T.</given-names></name> <name><surname>DiGirolamo</surname> <given-names>A. M.</given-names></name> <name><surname>Lu</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Early childhood development coming of age: science through the life course</article-title>. <source>Lancet</source> <volume>389</volume>, <fpage>77</fpage>&#x2013;<lpage>90</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(16)31389-7</pub-id>, PMID: <pub-id pub-id-type="pmid">27717614</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blas-Garc&#x00ED;a</surname> <given-names>A.</given-names></name> <name><surname>Polo</surname> <given-names>M.</given-names></name> <name><surname>Alegre</surname> <given-names>F.</given-names></name> <name><surname>Funes</surname> <given-names>H. A.</given-names></name> <name><surname>Mart&#x00ED;nez</surname> <given-names>E.</given-names></name> <name><surname>Apostolova</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Lack of mitochondrial toxicity of darunavir, raltegravir and rilpivirine in neurons and hepatocytes: a comparison with efavirenz</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>69</volume>, <fpage>2995</fpage>&#x2013;<lpage>3000</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dku262</pub-id>, PMID: <pub-id pub-id-type="pmid">25011651</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boivin</surname> <given-names>M. J.</given-names></name> <name><surname>Maliwichi-Senganimalunje</surname> <given-names>L.</given-names></name> <name><surname>Ogwang</surname> <given-names>L. W.</given-names></name> <name><surname>Kawalazira</surname> <given-names>R.</given-names></name> <name><surname>Sikorskii</surname> <given-names>A.</given-names></name> <name><surname>Familiar-Lopez</surname> <given-names>I.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study</article-title>. <source>Lancet HIV.</source> <volume>6</volume>, <fpage>e518</fpage>&#x2013;<lpage>e530</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2352-3018(19)30083-9</pub-id>, PMID: <pub-id pub-id-type="pmid">31122797</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bourin</surname> <given-names>M.</given-names></name> <name><surname>Hasco&#x00EB;t</surname> <given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>The mouse light/dark box test</article-title>. <source>Eur. J. Pharmacol.</source> <volume>463</volume>, <fpage>55</fpage>&#x2013;<lpage>65</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0014-2999(03)01274-3</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Budd</surname> <given-names>M. A.</given-names></name> <name><surname>Calli</surname> <given-names>K.</given-names></name> <name><surname>Samson</surname> <given-names>L.</given-names></name> <name><surname>Bowes</surname> <given-names>J.</given-names></name> <name><surname>Hsieh</surname> <given-names>A. Y. Y.</given-names></name> <name><surname>Forbes</surname> <given-names>J. C.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Blood mitochondrial DNA content in HIV-exposed uninfected children with autism Spectrum disorder</article-title>. <source>Viruses</source> <volume>10</volume>:<fpage>77</fpage>. doi: <pub-id pub-id-type="doi">10.3390/v10020077</pub-id>, PMID: <pub-id pub-id-type="pmid">29439467</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bulterys</surname> <given-names>M. A.</given-names></name> <name><surname>Njuguna</surname> <given-names>I.</given-names></name> <name><surname>Mahy</surname> <given-names>M.</given-names></name> <name><surname>Gulaid</surname> <given-names>L. A.</given-names></name> <name><surname>Powis</surname> <given-names>K. M.</given-names></name> <name><surname>Wedderburn</surname> <given-names>C. J.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Neurodevelopment among children exposed to HIV and uninfected in sub-Saharan Africa</article-title>. <source>J. Int. AIDS Soc.</source> <volume>26</volume>:<fpage>26159</fpage>. doi: <pub-id pub-id-type="doi">10.1002/jia2.26159</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burkey</surname> <given-names>M. D.</given-names></name> <name><surname>Murray</surname> <given-names>S. M.</given-names></name> <name><surname>Bangirana</surname> <given-names>P.</given-names></name> <name><surname>Familiar</surname> <given-names>I.</given-names></name> <name><surname>Opoka</surname> <given-names>R. O.</given-names></name> <name><surname>Nakasujja</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Executive function and attention-deficit/hyperactivity disorder in Ugandan children with perinatal HIV exposure</article-title>. <source>Global Mental Health.</source> <volume>2</volume>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1017/gmh.2015.2</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buzs&#x00E1;ki</surname> <given-names>G.</given-names></name></person-group> (<year>2002</year>). <article-title>Theta oscillations in the Hippocampus</article-title>. <source>Neuron</source> <volume>33</volume>, <fpage>325</fpage>&#x2013;<lpage>340</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0896-6273(02)00586-X</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cahill</surname> <given-names>L. S.</given-names></name> <name><surname>Lalibert&#x00E9;</surname> <given-names>C. L.</given-names></name> <name><surname>Ellegood</surname> <given-names>J.</given-names></name> <name><surname>Spring</surname> <given-names>S.</given-names></name> <name><surname>Gleave</surname> <given-names>J. A.</given-names></name> <name><surname>van Eede</surname> <given-names>M. C.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Preparation of fixed mouse brains for MRI</article-title>. <source>NeuroImage</source> <volume>60</volume>, <fpage>933</fpage>&#x2013;<lpage>939</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.01.100</pub-id>, PMID: <pub-id pub-id-type="pmid">22305951</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calamandrei</surname> <given-names>G.</given-names></name> <name><surname>Venerosi</surname> <given-names>A.</given-names></name> <name><surname>Branchi</surname> <given-names>I.</given-names></name> <name><surname>Chiarotti</surname> <given-names>F.</given-names></name> <name><surname>Verdina</surname> <given-names>A.</given-names></name> <name><surname>Bucci</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>1999a</year>). <article-title>Effects of prenatal AZT on mouse neurobehavioral development and passive avoidance learning</article-title>. <source>Neurotoxicol. Teratol.</source> <volume>21</volume>, <fpage>29</fpage>&#x2013;<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0892-0362(98)00035-X</pub-id>, PMID: <pub-id pub-id-type="pmid">10023799</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calamandrei</surname> <given-names>G.</given-names></name> <name><surname>Venerosi</surname> <given-names>A.</given-names></name> <name><surname>Branchi</surname> <given-names>I.</given-names></name> <name><surname>Valanzano</surname> <given-names>A.</given-names></name> <name><surname>Alleva</surname> <given-names>E.</given-names></name></person-group> (<year>2000</year>). <article-title>Prenatal exposure to anti-HIV drugs: long-term neurobehavioral effects of lamivudine (3TC) in CD-1 mice</article-title>. <source>Neurotoxicol. Teratol.</source> <volume>22</volume>, <fpage>369</fpage>&#x2013;<lpage>379</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0892-0362(00)00063-5</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calamandrei</surname> <given-names>G.</given-names></name> <name><surname>Venerosi</surname> <given-names>A.</given-names></name> <name><surname>Branchi</surname> <given-names>I.</given-names></name> <name><surname>Valanzano</surname> <given-names>A.</given-names></name> <name><surname>Puopolo</surname> <given-names>M.</given-names></name> <name><surname>Alleva</surname> <given-names>E.</given-names></name></person-group> (<year>1999b</year>). <article-title>Neurobehavioral effects of prenatal lamivudine (3TC) exposure in Preweaning mice</article-title>. <source>Neurotoxicol. Teratol.</source> <volume>21</volume>, <fpage>365</fpage>&#x2013;<lpage>373</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0892-0362(99)00018-5</pub-id>, PMID: <pub-id pub-id-type="pmid">10440480</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caniglia</surname> <given-names>E. C.</given-names></name> <name><surname>Patel</surname> <given-names>K.</given-names></name> <name><surname>Huo</surname> <given-names>Y.</given-names></name> <name><surname>Williams</surname> <given-names>P. L.</given-names></name> <name><surname>Kapetanovic</surname> <given-names>S.</given-names></name> <name><surname>Rich</surname> <given-names>K. C.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Atazanavir exposure in utero and neurodevelopment in infants: a comparative safety study</article-title>. <source>AIDS</source> <volume>30</volume>, <fpage>1267</fpage>&#x2013;<lpage>1277</lpage>. doi: <pub-id pub-id-type="doi">10.1097/QAD.0000000000001052</pub-id>, PMID: <pub-id pub-id-type="pmid">26867136</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chakravarty</surname> <given-names>M. M.</given-names></name> <name><surname>Steadman</surname> <given-names>P.</given-names></name> <name><surname>van Eede</surname> <given-names>M. C.</given-names></name> <name><surname>Calcott</surname> <given-names>R. D.</given-names></name> <name><surname>Gu</surname> <given-names>V.</given-names></name> <name><surname>Shaw</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Performing label-fusion-based segmentation using multiple automatically generated templates</article-title>. <source>Hum. Brain Mapp.</source> <volume>34</volume>, <fpage>2635</fpage>&#x2013;<lpage>2654</lpage>. doi: <pub-id pub-id-type="doi">10.1002/hbm.22092</pub-id>, PMID: <pub-id pub-id-type="pmid">22611030</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname> <given-names>O. Y.</given-names></name> <name><surname>Nikolaus</surname> <given-names>S.</given-names></name> <name><surname>Yang</surname> <given-names>Y. M.</given-names></name> <name><surname>Huston</surname> <given-names>J. P.</given-names></name></person-group> (<year>2022</year>). <article-title>Neuronal circuitry for recognition memory of object and place in rodent models</article-title>. <source>Neurosci. Biobehav. Rev.</source> <volume>141</volume>:<fpage>104855</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neubiorev.2022.104855</pub-id>, PMID: <pub-id pub-id-type="pmid">36089106</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chase</surname> <given-names>C.</given-names></name> <name><surname>Ware</surname> <given-names>J.</given-names></name> <name><surname>Hittelman</surname> <given-names>J.</given-names></name> <name><surname>Blasini</surname> <given-names>I.</given-names></name> <name><surname>Smith</surname> <given-names>M. R.</given-names></name> <name><surname>Llorente</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2000</year>). <article-title>Early cognitive and motor development among infants born to women infected with human immunodeficiency virus. Women and infants transmission study group</article-title>. <source>Pediatrics</source> <volume>106</volume>:<fpage>e25</fpage>. doi: <pub-id pub-id-type="doi">10.1542/peds.106.2.e25</pub-id>, PMID: <pub-id pub-id-type="pmid">10920181</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname> <given-names>M. K.</given-names></name> <name><surname>Worsley</surname> <given-names>K. J.</given-names></name> <name><surname>Paus</surname> <given-names>T.</given-names></name> <name><surname>Cherif</surname> <given-names>C.</given-names></name> <name><surname>Collins</surname> <given-names>D. L.</given-names></name> <name><surname>Giedd</surname> <given-names>J. N.</given-names></name> <etal/></person-group>. (<year>2001</year>). <article-title>A unified statistical approach to deformation-based morphometry</article-title>. <source>NeuroImage</source> <volume>14</volume>, <fpage>595</fpage>&#x2013;<lpage>606</lpage>. doi: <pub-id pub-id-type="doi">10.1006/nimg.2001.0862</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Citri</surname> <given-names>A.</given-names></name> <name><surname>Malenka</surname> <given-names>R. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Synaptic plasticity: multiple forms, functions, and mechanisms</article-title>. <source>Neuropsychopharmacology</source> <volume>33</volume>, <fpage>18</fpage>&#x2013;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.1038/sj.npp.1301559</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cockcroft</surname> <given-names>K.</given-names></name> <name><surname>Milligan</surname> <given-names>R.</given-names></name></person-group> (<year>2019</year>). <article-title>Working memory structure in atypical development: HIV-infected and HIV-exposed, uninfected school beginners</article-title>. <source>Dev. Neuropsychol.</source> <volume>44</volume>, <fpage>248</fpage>&#x2013;<lpage>272</lpage>. doi: <pub-id pub-id-type="doi">10.1080/87565641.2018.1564309</pub-id>, PMID: <pub-id pub-id-type="pmid">30623681</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname> <given-names>J.</given-names></name> <name><surname>D&#x2019;Agostino</surname> <given-names>L.</given-names></name> <name><surname>Wilson</surname> <given-names>J.</given-names></name> <name><surname>Tuzer</surname> <given-names>F.</given-names></name> <name><surname>Torres</surname> <given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>Astrocyte senescence and metabolic changes in response to HIV antiretroviral therapy drugs</article-title>. <source>Front. Aging Neurosci.</source> <volume>9</volume>:<fpage>281</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnagi.2017.00281</pub-id></citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dazai</surname> <given-names>J.</given-names></name> <name><surname>Spring</surname> <given-names>S.</given-names></name> <name><surname>Cahill</surname> <given-names>L. S.</given-names></name> <name><surname>Mark</surname> <given-names>H. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Multiple-mouse neuroanatomical magnetic resonance imaging</article-title>. <source>J. Vis. Exp.</source> <volume>48</volume>:<fpage>2497</fpage>. doi: <pub-id pub-id-type="doi">10.3791/2497-v</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Benedetto</surname> <given-names>I.</given-names></name> <name><surname>Trunfio</surname> <given-names>M.</given-names></name> <name><surname>Guastamacchia</surname> <given-names>G.</given-names></name> <name><surname>Bonora</surname> <given-names>S.</given-names></name> <name><surname>Calcagno</surname> <given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugs</article-title>. <source>J. Neuro-Oncol.</source> <volume>26</volume>, <fpage>642</fpage>&#x2013;<lpage>651</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s13365-020-00874-9</pub-id>, PMID: <pub-id pub-id-type="pmid">32737860</pub-id></citation></ref>
<ref id="ref36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Cock</surname> <given-names>K. M.</given-names></name> <name><surname>Fowler</surname> <given-names>M. G.</given-names></name> <name><surname>Mercier</surname> <given-names>E.</given-names></name> <name><surname>De Vincenzi</surname> <given-names>I.</given-names></name> <name><surname>Saba</surname> <given-names>J.</given-names></name> <name><surname>Hoff</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2000</year>). <article-title>Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice</article-title>. <source>JAMA</source> <volume>283</volume>, <fpage>1175</fpage>&#x2013;<lpage>1182</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.283.9.1175</pub-id></citation></ref>
<ref id="ref37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Guzman</surname> <given-names>A. E.</given-names></name> <name><surname>Wong</surname> <given-names>M. D.</given-names></name> <name><surname>Gleave</surname> <given-names>J. A.</given-names></name> <name><surname>Nieman</surname> <given-names>B. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Variations in post-perfusion immersion fixation and storage alter MRI measurements of mouse brain morphometry</article-title>. <source>NeuroImage</source> <volume>142</volume>, <fpage>687</fpage>&#x2013;<lpage>695</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroimage.2016.06.028</pub-id>, PMID: <pub-id pub-id-type="pmid">27335314</pub-id></citation></ref>
<ref id="ref1"><citation citation-type="other">Department of Health and Human Services. (<year>2024</year>) Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. Available at: <ext-link xlink:href="https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-drug-use-pregnant-overview?view=full" ext-link-type="uri">https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-drug-use-pregnant-overview?view=full</ext-link></citation></ref>
<ref id="ref38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Desmonde</surname> <given-names>S.</given-names></name> <name><surname>Goetghebuer</surname> <given-names>T.</given-names></name> <name><surname>Thorne</surname> <given-names>C.</given-names></name> <name><surname>Leroy</surname> <given-names>V.</given-names></name></person-group> (<year>2016</year>). <article-title>Health and survival of HIV perinatally exposed but uninfected children born to HIV-infected mothers</article-title>. <source>Curr. Opin. HIV AIDS</source> <volume>11</volume>, <fpage>465</fpage>&#x2013;<lpage>476</lpage>. doi: <pub-id pub-id-type="doi">10.1097/COH.0000000000000300</pub-id>, PMID: <pub-id pub-id-type="pmid">27716731</pub-id></citation></ref>
<ref id="ref39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dieni</surname> <given-names>S.</given-names></name> <name><surname>Rees</surname> <given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>Dendritic morphology is altered in hippocampal neurons following prenatal compromise</article-title>. <source>J. Neurobiol.</source> <volume>55</volume>, <fpage>41</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1002/neu.10194</pub-id>, PMID: <pub-id pub-id-type="pmid">12605458</pub-id></citation></ref>
<ref id="ref40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Diering</surname> <given-names>G. H.</given-names></name> <name><surname>Huganir</surname> <given-names>R. L.</given-names></name></person-group> (<year>2018</year>). <article-title>The AMPA receptor code of synaptic plasticity</article-title>. <source>Neuron</source> <volume>100</volume>, <fpage>314</fpage>&#x2013;<lpage>329</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2018.10.018</pub-id>, PMID: <pub-id pub-id-type="pmid">30359599</pub-id></citation></ref>
<ref id="ref41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname> <given-names>W.</given-names></name> <name><surname>Chen</surname> <given-names>H.</given-names></name> <name><surname>Sit</surname> <given-names>T.</given-names></name> <name><surname>Han</surname> <given-names>Y.</given-names></name> <name><surname>Song</surname> <given-names>F.</given-names></name> <name><surname>Vyssotski</surname> <given-names>A. L.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Characterization of exploratory patterns and hippocampal&#x2013;prefrontal network oscillations during the emergence of free exploration</article-title>. <source>Sci Bull (Beijing).</source> <volume>66</volume>, <fpage>2238</fpage>&#x2013;<lpage>2250</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.scib.2021.05.018</pub-id>, PMID: <pub-id pub-id-type="pmid">36654115</pub-id></citation></ref>
<ref id="ref42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dorr</surname> <given-names>A. E.</given-names></name> <name><surname>Lerch</surname> <given-names>J. P.</given-names></name> <name><surname>Spring</surname> <given-names>S.</given-names></name> <name><surname>Kabani</surname> <given-names>N.</given-names></name> <name><surname>Henkelman</surname> <given-names>R. M.</given-names></name></person-group> (<year>2008</year>). <article-title>High resolution three-dimensional brain atlas using an average magnetic resonance image of 40 adult C57Bl/6J mice</article-title>. <source>NeuroImage</source> <volume>42</volume>, <fpage>60</fpage>&#x2013;<lpage>69</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroimage.2008.03.037</pub-id>, PMID: <pub-id pub-id-type="pmid">18502665</pub-id></citation></ref>
<ref id="ref43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dunk</surname> <given-names>C. E.</given-names></name> <name><surname>Serghides</surname> <given-names>L.</given-names></name></person-group> (<year>2022</year>). <article-title>Protease inhibitor-based antiretroviral therapy in pregnancy: effects on hormones, placenta, and decidua</article-title>. <source>Lancet HIV.</source> <volume>9</volume>, <fpage>e120</fpage>&#x2013;<lpage>e129</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2352-3018(21)00249-6</pub-id>, PMID: <pub-id pub-id-type="pmid">34863352</pub-id></citation></ref>
<ref id="ref45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname> <given-names>R.</given-names></name> <name><surname>Langford</surname> <given-names>D.</given-names></name> <name><surname>Masliah</surname> <given-names>E.</given-names></name></person-group> (<year>2007</year>). <article-title>HIV and antiretroviral therapy in the brain: neuronal injury and repair</article-title>. <source>Nat. Rev. Neurosci.</source> <volume>8</volume>, <fpage>33</fpage>&#x2013;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrn2040</pub-id>, PMID: <pub-id pub-id-type="pmid">17180161</pub-id></citation></ref>
<ref id="ref46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Estanislau</surname> <given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Cues to the usefulness of grooming behavior in the evaluation of anxiety in the elevated plus-maze</article-title>. <source>Psychol. Neurosci.</source> <volume>5</volume>, <fpage>105</fpage>&#x2013;<lpage>112</lpage>. doi: <pub-id pub-id-type="doi">10.3922/j.psns.2012.1.14</pub-id></citation></ref>
<ref id="ref47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname> <given-names>C.</given-names></name> <name><surname>Jones</surname> <given-names>C. E.</given-names></name> <name><surname>Prendergast</surname> <given-names>A. J.</given-names></name></person-group> (<year>2016</year>). <article-title>HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination</article-title>. <source>Lancet Infect. Dis.</source> <volume>16</volume>, <fpage>e92</fpage>&#x2013;<lpage>e107</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1473-3099(16)00055-4</pub-id>, PMID: <pub-id pub-id-type="pmid">27049574</pub-id></citation></ref>
<ref id="ref48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Favarato</surname> <given-names>G.</given-names></name> <name><surname>Townsend</surname> <given-names>C. L.</given-names></name> <name><surname>Bailey</surname> <given-names>H.</given-names></name> <name><surname>Peters</surname> <given-names>H.</given-names></name> <name><surname>Tookey</surname> <given-names>P. A.</given-names></name> <name><surname>Taylor</surname> <given-names>G. P.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Protease inhibitors and preterm delivery: another piece in the puzzle</article-title>. <source>AIDS</source> <volume>32</volume>, <fpage>243</fpage>&#x2013;<lpage>252</lpage>. doi: <pub-id pub-id-type="doi">10.1097/QAD.0000000000001694</pub-id></citation></ref>
<ref id="ref49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fitting</surname> <given-names>S.</given-names></name> <name><surname>Booze</surname> <given-names>R. M.</given-names></name> <name><surname>Mactutus</surname> <given-names>C. F.</given-names></name></person-group> (<year>2008</year>). <article-title>Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and tat: differential effects on behavior and the relationship to stereological hippocampal measures</article-title>. <source>Brain Res.</source> <volume>1232</volume>, <fpage>139</fpage>&#x2013;<lpage>154</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.brainres.2008.07.032</pub-id>, PMID: <pub-id pub-id-type="pmid">18674522</pub-id></citation></ref>
<ref id="ref50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname> <given-names>E. G.</given-names></name> <name><surname>Gendelman</surname> <given-names>H. E.</given-names></name> <name><surname>Bade</surname> <given-names>A. N.</given-names></name></person-group> (<year>2022</year>). <article-title>HIV-1 integrase Strand transfer inhibitors and neurodevelopment</article-title>. <source>Pharmaceuticals.</source> <volume>15</volume>:<fpage>1533</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ph15121533</pub-id>, PMID: <pub-id pub-id-type="pmid">36558984</pub-id></citation></ref>
<ref id="ref51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname> <given-names>L. M.</given-names></name> <name><surname>Stanley</surname> <given-names>G. B.</given-names></name> <name><surname>Brown</surname> <given-names>E. N.</given-names></name></person-group> (<year>2004</year>). <article-title>Hippocampal plasticity across multiple days of exposure to novel environments</article-title>. <source>J. Neurosci.</source> <volume>24</volume>, <fpage>7681</fpage>&#x2013;<lpage>7689</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1958-04.2004</pub-id>, PMID: <pub-id pub-id-type="pmid">15342735</pub-id></citation></ref>
<ref id="ref52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Friedel</surname> <given-names>M.</given-names></name> <name><surname>van Eede</surname> <given-names>M. C.</given-names></name> <name><surname>Pipitone</surname> <given-names>J.</given-names></name> <name><surname>Mallar Chakravarty</surname> <given-names>M.</given-names></name> <name><surname>Lerch</surname> <given-names>J. P.</given-names></name></person-group> (<year>2014</year>). <article-title>Pydpiper: a flexible toolkit for constructing novel registration pipelines</article-title>. <source>Front. Neuroinform.</source> <volume>8</volume>:<fpage>67</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fninf.2014.00067</pub-id></citation></ref>
<ref id="ref53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gilmore</surname> <given-names>J. C.</given-names></name> <name><surname>Zhang</surname> <given-names>G.</given-names></name> <name><surname>Cameron</surname> <given-names>D. W.</given-names></name> <name><surname>Serghides</surname> <given-names>L.</given-names></name> <name><surname>Bendayan</surname> <given-names>R.</given-names></name></person-group> (<year>2021</year>). <article-title>Impact of in-utero antiretroviral drug exposure on expression of membrane-associated transporters in mouse placenta and fetal brain</article-title>. <source>AIDS</source> <volume>35</volume>, <fpage>2249</fpage>&#x2013;<lpage>2258</lpage>. doi: <pub-id pub-id-type="doi">10.1097/QAD.0000000000003009</pub-id>, PMID: <pub-id pub-id-type="pmid">34175869</pub-id></citation></ref>
<ref id="ref54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gliwi&#x0144;ska</surname> <given-names>A.</given-names></name> <name><surname>Czubili&#x0144;ska-&#x0141;ada</surname> <given-names>J.</given-names></name> <name><surname>Wi&#x0119;ckiewicz</surname> <given-names>G.</given-names></name> <name><surname>&#x015A;wi&#x0119;tochowska</surname> <given-names>E.</given-names></name> <name><surname>Bade&#x0144;ski</surname> <given-names>A.</given-names></name> <name><surname>Dworak</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>The role of brain-derived neurotrophic factor (BDNF) in diagnosis and treatment of epilepsy, depression, schizophrenia, anorexia nervosa and Alzheimer&#x0026;rsquo; s disease as highly drug-resistant diseases: a narrative review</article-title>. <source>Brain Sci.</source> <volume>13</volume>:<fpage>163</fpage>. doi: <pub-id pub-id-type="doi">10.3390/brainsci13020163</pub-id>, PMID: <pub-id pub-id-type="pmid">36831706</pub-id></citation></ref>
<ref id="ref55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>H&#x00E5;nell</surname> <given-names>A.</given-names></name> <name><surname>Marklund</surname> <given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>Structured evaluation of rodent behavioral tests used in drug discovery research</article-title>. <source>Front. Behav. Neurosci.</source> <volume>8</volume>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.3389/fnbeh.2014.00252</pub-id></citation></ref>
<ref id="ref56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Himes</surname> <given-names>S. K.</given-names></name> <name><surname>Huo</surname> <given-names>Y.</given-names></name> <name><surname>Siberry</surname> <given-names>G. K.</given-names></name> <name><surname>Williams</surname> <given-names>P. L.</given-names></name> <name><surname>Rice</surname> <given-names>M. L.</given-names></name> <name><surname>Sirois</surname> <given-names>P. A.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Meconium Atazanavir concentrations and early language outcomes in HIV-exposed uninfected infants with prenatal Atazanavir exposure</article-title>. <source>J. Acquir. Immune Defic. Syndr.</source> <volume>69</volume>, <fpage>178</fpage>&#x2013;<lpage>186</lpage>. doi: <pub-id pub-id-type="doi">10.1097/QAI.0000000000000558</pub-id>, PMID: <pub-id pub-id-type="pmid">26009830</pub-id></citation></ref>
<ref id="ref57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Illa</surname> <given-names>M.</given-names></name> <name><surname>Eixarch</surname> <given-names>E.</given-names></name> <name><surname>Batalle</surname> <given-names>D.</given-names></name> <name><surname>Arbat-Plana</surname> <given-names>A.</given-names></name> <name><surname>Mu&#x00F1;oz-Moreno</surname> <given-names>E.</given-names></name> <name><surname>Figueras</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Long-term Functional outcomes and correlation with regional brain Connectivity by MRI diffusion Tractography metrics in a near-term rabbit model of intrauterine growth restriction</article-title>. <source>PLoS One</source> <volume>8</volume>:<fpage>e76453</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0076453</pub-id></citation></ref>
<ref id="ref58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>A.</given-names></name> <name><surname>Varberg</surname> <given-names>Z.</given-names></name> <name><surname>Benhardus</surname> <given-names>J.</given-names></name> <name><surname>Maahs</surname> <given-names>A.</given-names></name> <name><surname>Schrater</surname> <given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>The hippocampus and exploration: dynamically evolving behavior and neural representations</article-title>. <source>Front. Hum. Neurosci.</source> <volume>6</volume>:<fpage>17412</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnhum.2012.00216</pub-id></citation></ref>
<ref id="ref59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jourdi</surname> <given-names>H.</given-names></name> <name><surname>Hsu</surname> <given-names>Y. T.</given-names></name> <name><surname>Zhou</surname> <given-names>M.</given-names></name> <name><surname>Qin</surname> <given-names>G.</given-names></name> <name><surname>Bi</surname> <given-names>X.</given-names></name> <name><surname>Baudry</surname> <given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Positive AMPA receptor modulation rapidly stimulates BDNF release and increases dendritic mRNA translation</article-title>. <source>J. Neurosci.</source> <volume>29</volume>, <fpage>8688</fpage>&#x2013;<lpage>8697</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.6078-08.2009</pub-id>, PMID: <pub-id pub-id-type="pmid">19587275</pub-id></citation></ref>
<ref id="ref60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaidanovich-Beilin</surname> <given-names>O.</given-names></name> <name><surname>Lipina</surname> <given-names>T.</given-names></name> <name><surname>Vukobradovic</surname> <given-names>I.</given-names></name> <name><surname>Roder</surname> <given-names>J.</given-names></name> <name><surname>Woodgett</surname> <given-names>J. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Assessment of social interaction behaviors</article-title>. <source>J. Vis. Exp.</source> <volume>48</volume>:<fpage>2473</fpage>. doi: <pub-id pub-id-type="doi">10.3791/2473-v</pub-id></citation></ref>
<ref id="ref61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kala</surname> <given-names>S.</given-names></name> <name><surname>Watson</surname> <given-names>B.</given-names></name> <name><surname>Zhang</surname> <given-names>J. G.</given-names></name> <name><surname>Papp</surname> <given-names>E.</given-names></name> <name><surname>Guzman Lenis</surname> <given-names>M.</given-names></name> <name><surname>Dennehy</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Improving the clinical relevance of a mouse pregnancy model of antiretroviral toxicity; a pharmacokinetic dosing-optimization study of current HIV antiretroviral regimens</article-title>. <source>Antivir. Res.</source> <volume>159</volume>, <fpage>45</fpage>&#x2013;<lpage>54</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.antiviral.2018.09.008</pub-id>, PMID: <pub-id pub-id-type="pmid">30236532</pub-id></citation></ref>
<ref id="ref62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalueff</surname> <given-names>A. V.</given-names></name> <name><surname>Stewart</surname> <given-names>A. M.</given-names></name> <name><surname>Song</surname> <given-names>C.</given-names></name> <name><surname>Berridge</surname> <given-names>K. C.</given-names></name> <name><surname>Graybiel</surname> <given-names>A. M.</given-names></name> <name><surname>Fentress</surname> <given-names>J. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Neurobiology of rodent self-grooming and its value for translational neuroscience</article-title>. <source>Nat. Rev. Neurosci.</source> <volume>17</volume>, <fpage>45</fpage>&#x2013;<lpage>59</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrn.2015.8</pub-id>, PMID: <pub-id pub-id-type="pmid">26675822</pub-id></citation></ref>
<ref id="ref63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keifer</surname> <given-names>J.</given-names></name></person-group> (<year>2022</year>). <article-title>Regulation of AMPAR trafficking in synaptic plasticity by BDNF and the impact of neurodegenerative disease</article-title>. <source>J. Neurosci. Res.</source> <volume>100</volume>, <fpage>979</fpage>&#x2013;<lpage>991</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jnr.25022</pub-id></citation></ref>
<ref id="ref64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitamura</surname> <given-names>T.</given-names></name> <name><surname>MacDonald</surname> <given-names>C. J.</given-names></name> <name><surname>Tonegawa</surname> <given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Entorhinal-hippocampal neuronal circuits bridge temporally discontiguous events</article-title>. <source>Learn. Mem.</source> <volume>22</volume>, <fpage>438</fpage>&#x2013;<lpage>443</lpage>. doi: <pub-id pub-id-type="doi">10.1101/lm.038687.115</pub-id>, PMID: <pub-id pub-id-type="pmid">26286654</pub-id></citation></ref>
<ref id="ref65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitamura</surname> <given-names>T.</given-names></name> <name><surname>Ogawa</surname> <given-names>S. K.</given-names></name> <name><surname>Roy</surname> <given-names>D. S.</given-names></name> <name><surname>Okuyama</surname> <given-names>T.</given-names></name> <name><surname>Morrissey</surname> <given-names>M. D.</given-names></name> <name><surname>Smith</surname> <given-names>L. M.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Engrams and circuits crucial for systems consolidation of a memory</article-title>. <source>Science</source> <volume>356</volume>, <fpage>73</fpage>&#x2013;<lpage>78</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.aam6808</pub-id></citation></ref>
<ref id="ref66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kornau</surname> <given-names>H. C.</given-names></name> <name><surname>Schenker</surname> <given-names>L. T.</given-names></name> <name><surname>Kennedy</surname> <given-names>M. B.</given-names></name> <name><surname>Seeburg</surname> <given-names>P. H.</given-names></name></person-group> (<year>1995</year>). <article-title>Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95</article-title>. <source>Science</source> <volume>269</volume>, <fpage>1737</fpage>&#x2013;<lpage>1740</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.7569905</pub-id></citation></ref>
<ref id="ref67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lanman</surname> <given-names>T.</given-names></name> <name><surname>Letendre</surname> <given-names>S.</given-names></name> <name><surname>Ma</surname> <given-names>Q.</given-names></name> <name><surname>Bang</surname> <given-names>A.</given-names></name> <name><surname>Ellis</surname> <given-names>R.</given-names></name></person-group> (<year>2021</year>). <article-title>CNS neurotoxicity of Antiretrovirals</article-title>. <source>J. Neuroimmune Pharmacol.</source> <volume>16</volume>, <fpage>130</fpage>&#x2013;<lpage>143</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11481-019-09886-7</pub-id>, PMID: <pub-id pub-id-type="pmid">31823251</pub-id></citation></ref>
<ref id="ref68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>La-Vu</surname> <given-names>M.</given-names></name> <name><surname>Tobias</surname> <given-names>B. C.</given-names></name> <name><surname>Schuette</surname> <given-names>P. J.</given-names></name> <name><surname>Adhikari</surname> <given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>To approach or avoid: an introductory overview of the study of anxiety using rodent assays</article-title>. <source>Front. Behav. Neurosci.</source> <volume>14</volume>:<fpage>145</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnbeh.2020.00145</pub-id>, PMID: <pub-id pub-id-type="pmid">33005134</pub-id></citation></ref>
<ref id="ref69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le Doar&#x00E9;</surname> <given-names>K.</given-names></name> <name><surname>Bland</surname> <given-names>R.</given-names></name> <name><surname>Newell</surname> <given-names>M. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Neurodevelopment in children born to HIV-infected mothers by infection and treatment status</article-title>. <source>Pediatrics</source> <volume>130</volume>, <fpage>e1326</fpage>&#x2013;<lpage>e1344</lpage>. doi: <pub-id pub-id-type="doi">10.1542/peds.2012-0405</pub-id>, PMID: <pub-id pub-id-type="pmid">23118140</pub-id></citation></ref>
<ref id="ref70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le Roux</surname> <given-names>S. M.</given-names></name> <name><surname>Donald</surname> <given-names>K. A.</given-names></name> <name><surname>Brittain</surname> <given-names>K.</given-names></name> <name><surname>Phillips</surname> <given-names>T. K.</given-names></name> <name><surname>Zerbe</surname> <given-names>A.</given-names></name> <name><surname>Nguyen</surname> <given-names>K. K.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Neurodevelopment of breastfed HIV-exposed uninfected and HIV-unexposed children in South Africa</article-title>. <source>AIDS</source> <volume>32</volume>, <fpage>1781</fpage>&#x2013;<lpage>1791</lpage>. doi: <pub-id pub-id-type="doi">10.1097/QAD.0000000000001872</pub-id>, PMID: <pub-id pub-id-type="pmid">29794831</pub-id></citation></ref>
<ref id="ref71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>I.</given-names></name> <name><surname>Kesner</surname> <given-names>R. P.</given-names></name></person-group> (<year>2002</year>). <article-title>Differential contribution of NMDA receptors in hippocampal subregions to spatial working memory</article-title>. <source>Nat. Neurosci.</source> <volume>5</volume>, <fpage>162</fpage>&#x2013;<lpage>168</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nn790</pub-id>, PMID: <pub-id pub-id-type="pmid">11780144</pub-id></citation></ref>
<ref id="ref72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liner</surname> <given-names>K. J.</given-names></name> <name><surname>Ro</surname> <given-names>M. J.</given-names></name> <name><surname>Robertson</surname> <given-names>K. R.</given-names></name></person-group> (<year>2010</year>). <article-title>HIV, antiretroviral therapies, and the brain</article-title>. <source>Current HIV/AIDS Reports</source> <volume>7</volume>, <fpage>85</fpage>&#x2013;<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11904-010-0042-8</pub-id></citation></ref>
<ref id="ref73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>H.</given-names></name> <name><surname>Huang</surname> <given-names>X.</given-names></name> <name><surname>Xu</surname> <given-names>J.</given-names></name> <name><surname>Mao</surname> <given-names>H.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Ren</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Dissection of the relationship between anxiety and stereotyped self-grooming using the Shank3B mutant autistic model, acute stress model and chronic pain model</article-title>. <source>Neurobiol Stress.</source> <volume>15</volume>:<fpage>100417</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ynstr.2021.100417</pub-id></citation></ref>
<ref id="ref74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>D. Y.</given-names></name> <name><surname>Shen</surname> <given-names>X. M.</given-names></name> <name><surname>Yuan</surname> <given-names>F. F.</given-names></name> <name><surname>Guo</surname> <given-names>O. Y.</given-names></name> <name><surname>Zhong</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>J. G.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>The physiology of BDNF and its relationship with ADHD</article-title>. <source>Mol. Neurobiol.</source> <volume>52</volume>, <fpage>1467</fpage>&#x2013;<lpage>1476</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12035-014-8956-6</pub-id>, PMID: <pub-id pub-id-type="pmid">25354496</pub-id></citation></ref>
<ref id="ref75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname> <given-names>K. J.</given-names></name> <name><surname>Schmittgen</surname> <given-names>T. D.</given-names></name></person-group> (<year>2001</year>). <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method</article-title>. <source>Methods</source> <volume>25</volume>, <fpage>402</fpage>&#x2013;<lpage>408</lpage>. doi: <pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id></citation></ref>
<ref id="ref76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>L&#x00FC;scher</surname> <given-names>C.</given-names></name> <name><surname>Malenka</surname> <given-names>R. C.</given-names></name></person-group> (<year>2012</year>). <article-title>NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD)</article-title>. <source>Cold Spring Harb. Perspect. Biol.</source> <volume>4</volume>, <fpage>1</fpage>&#x2013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.1101/cshperspect.a005710</pub-id></citation></ref>
<ref id="ref77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Madlala</surname> <given-names>H. P.</given-names></name> <name><surname>Myer</surname> <given-names>L.</given-names></name> <name><surname>Malaba</surname> <given-names>T. R.</given-names></name> <name><surname>Newell</surname> <given-names>M. L.</given-names></name></person-group> (<year>2020</year>). <article-title>Neurodevelopment of HIV-exposed uninfected children in Cape Town, South Africa</article-title>. <source>PLoS One</source> <volume>15</volume>:<fpage>e0242244</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0242244</pub-id>, PMID: <pub-id pub-id-type="pmid">33206724</pub-id></citation></ref>
<ref id="ref78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malberg</surname> <given-names>J. E.</given-names></name> <name><surname>Eisch</surname> <given-names>A. J.</given-names></name> <name><surname>Nestler</surname> <given-names>E. J.</given-names></name> <name><surname>Duman</surname> <given-names>R. S.</given-names></name></person-group> (<year>2000</year>). <article-title>Chronic antidepressant treatment increases neurogenesis in adult rat Hippocampus</article-title>. <source>J. Neurosci.</source> <volume>20</volume>, <fpage>9104</fpage>&#x2013;<lpage>9110</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-24-09104.2000</pub-id>, PMID: <pub-id pub-id-type="pmid">11124987</pub-id></citation></ref>
<ref id="ref79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malenka</surname> <given-names>R. C.</given-names></name></person-group> (<year>2003</year>). <article-title>The long-term potential of LTP</article-title>. <source>Nat. Rev. Neurosci.</source> <volume>4</volume>, <fpage>923</fpage>&#x2013;<lpage>926</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrn1258</pub-id></citation></ref>
<ref id="ref80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mallard</surname> <given-names>C.</given-names></name> <name><surname>Loeliger</surname> <given-names>M.</given-names></name> <name><surname>Copolov</surname> <given-names>D.</given-names></name> <name><surname>Rees</surname> <given-names>S.</given-names></name></person-group> (<year>2000</year>). <article-title>Reduced number of neurons in the hippocampus and the cerebellum in the postnatal guinea-pig following intrauterine growth-restriction</article-title>. <source>Neuroscience</source> <volume>100</volume>, <fpage>327</fpage>&#x2013;<lpage>333</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0306-4522(00)00271-2</pub-id>, PMID: <pub-id pub-id-type="pmid">11008170</pub-id></citation></ref>
<ref id="ref81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x00ED;nez-Turrillas</surname> <given-names>R.</given-names></name> <name><surname>Del R&#x00ED;o</surname> <given-names>J.</given-names></name> <name><surname>Frechilla</surname> <given-names>D.</given-names></name></person-group> (<year>2005</year>). <article-title>Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment</article-title>. <source>Neuropharmacology</source> <volume>49</volume>, <fpage>1178</fpage>&#x2013;<lpage>1188</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuropharm.2005.07.006</pub-id>, PMID: <pub-id pub-id-type="pmid">16143352</pub-id></citation></ref>
<ref id="ref82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Turrillas</surname> <given-names>R.</given-names></name> <name><surname>Frechilla</surname> <given-names>D.</given-names></name> <name><surname>Del R&#x00ED;o</surname> <given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus</article-title>. <source>Neuropharmacology</source> <volume>43</volume>, <fpage>1230</fpage>&#x2013;<lpage>1237</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0028-3908(02)00299-X</pub-id>, PMID: <pub-id pub-id-type="pmid">12527472</pub-id></citation></ref>
<ref id="ref83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McHenry</surname> <given-names>M. S.</given-names></name> <name><surname>Balogun</surname> <given-names>K. A.</given-names></name> <name><surname>McDonald</surname> <given-names>B. C.</given-names></name> <name><surname>Vreeman</surname> <given-names>R. C.</given-names></name> <name><surname>Whipple</surname> <given-names>E. C.</given-names></name> <name><surname>Serghides</surname> <given-names>L.</given-names></name></person-group> (<year>2019</year>). <article-title>In utero exposure to HIV and/or antiretroviral therapy: a systematic review of preclinical and clinical evidence of cognitive outcomes</article-title>. <source>J. Int. AIDS Soc.</source> <volume>22</volume>:<fpage>e25275</fpage>. doi: <pub-id pub-id-type="doi">10.1002/jia2.25275</pub-id>, PMID: <pub-id pub-id-type="pmid">30983111</pub-id></citation></ref>
<ref id="ref84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McHenry</surname> <given-names>M. S.</given-names></name> <name><surname>McAteer</surname> <given-names>C. I.</given-names></name> <name><surname>Oyungu</surname> <given-names>E.</given-names></name> <name><surname>McDonald</surname> <given-names>B. C.</given-names></name> <name><surname>Bosma</surname> <given-names>C. B.</given-names></name> <name><surname>Mpofu</surname> <given-names>P. B.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Neurodevelopment in Young children born to HIV-infected mothers: a Meta-analysis</article-title>. <source>Pediatrics</source> <volume>141</volume>:<fpage>e20172888</fpage>. doi: <pub-id pub-id-type="doi">10.1542/peds.2017-2888</pub-id></citation></ref>
<ref id="ref85"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Melillo</surname> <given-names>R</given-names></name></person-group>. (<year>2011</year>). <source>Primitive reflexes and their relationship to delayed cortical maturation, under connectivity and functional disconnection in childhood neurobehavioral disorders</source>. <publisher-loc>San Francisco, CA</publisher-loc>: <publisher-name>Public Library of Science</publisher-name>. <volume>1</volume>, <fpage>279</fpage>&#x2013;<lpage>314</lpage>.</citation></ref>
<ref id="ref86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mensi</surname> <given-names>M.</given-names></name> <name><surname>Ahishakiye</surname> <given-names>A.</given-names></name> <name><surname>Journeay</surname> <given-names>K.</given-names></name> <name><surname>Baiocco</surname> <given-names>R.</given-names></name> <name><surname>Betancourt</surname> <given-names>T. S.</given-names></name> <name><surname>Paganotti</surname> <given-names>G. M.</given-names></name></person-group> (<year>2023</year>). <article-title>HIV-exposed uninfected children: a systematic review on psychological well-being and association with school performances in Africa</article-title>. <source>Int. J. Environ. Res. Public Health</source> <volume>20</volume>:<fpage>2499</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph20032499</pub-id></citation></ref>
<ref id="ref87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Milligan</surname> <given-names>R.</given-names></name> <name><surname>Cockcroft</surname> <given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Working memory profiles in HIV-exposed, uninfected and HIV-infected children: a comparison with Neurotypical controls</article-title>. <source>Front. Hum. Neurosci.</source> <volume>11</volume>:<fpage>11</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnhum.2017.00348</pub-id></citation></ref>
<ref id="ref88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Newcomer</surname> <given-names>J. W.</given-names></name> <name><surname>Krystal</surname> <given-names>J. H.</given-names></name></person-group> (<year>2001</year>). <article-title>NMDA receptor regulation of memory and behavior in humans</article-title>. <source>Hippocampus</source> <volume>11</volume>, <fpage>529</fpage>&#x2013;<lpage>542</lpage>. doi: <pub-id pub-id-type="doi">10.1002/hipo.1069</pub-id></citation></ref>
<ref id="ref89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nicoll</surname> <given-names>R. A.</given-names></name></person-group> (<year>2003</year>). <article-title>Expression mechanisms underlying long-term potentiation: a postsynaptic view</article-title>. <source>Philosop. Trans. Royal Society B: Biolog. Sci.</source> <volume>358</volume>, <fpage>721</fpage>&#x2013;<lpage>726</lpage>. doi: <pub-id pub-id-type="doi">10.1098/rstb.2002.1228</pub-id>, PMID: <pub-id pub-id-type="pmid">12740118</pub-id></citation></ref>
<ref id="ref90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nieman</surname> <given-names>B. J.</given-names></name> <name><surname>van Eede</surname> <given-names>M. C.</given-names></name> <name><surname>Spring</surname> <given-names>S.</given-names></name> <name><surname>Dazai</surname> <given-names>J.</given-names></name> <name><surname>Henkelman</surname> <given-names>R. M.</given-names></name> <name><surname>Lerch</surname> <given-names>J. P.</given-names></name></person-group> (<year>2018</year>). <article-title>MRI to assess neurological function</article-title>. <source>Curr Protoc Mouse Biol.</source> <volume>8</volume>:<fpage>e44</fpage>. doi: <pub-id pub-id-type="doi">10.1002/cpmo.44</pub-id></citation></ref>
<ref id="ref91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nooka</surname> <given-names>S.</given-names></name> <name><surname>Ghorpade</surname> <given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>HIV-1-associated inflammation and antiretroviral therapy regulate astrocyte endoplasmic reticulum stress responses</article-title>. <source>Cell Death Dis.</source> <volume>3</volume>:<fpage>17061</fpage>. doi: <pub-id pub-id-type="doi">10.1038/cddiscovery.2017.61</pub-id>, PMID: <pub-id pub-id-type="pmid">29354290</pub-id></citation></ref>
<ref id="ref92"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nozyce</surname> <given-names>M. L.</given-names></name> <name><surname>Huo</surname> <given-names>Y.</given-names></name> <name><surname>Williams</surname> <given-names>P. L.</given-names></name> <name><surname>Kapetanovic</surname> <given-names>S.</given-names></name> <name><surname>Hazra</surname> <given-names>R.</given-names></name> <name><surname>Nichols</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age</article-title>. <source>Pediatr. Infect. Dis. J.</source> <volume>33</volume>, <fpage>1128</fpage>&#x2013;<lpage>1133</lpage>. doi: <pub-id pub-id-type="doi">10.1097/INF.0000000000000410</pub-id>, PMID: <pub-id pub-id-type="pmid">25361407</pub-id></citation></ref>
<ref id="ref93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>AMPA receptor trafficking for postsynaptic potentiation</article-title>. <source>Front. Cell. Neurosci.</source> <volume>12</volume>, <fpage>1</fpage>&#x2013;<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.3389/fncel.2018.00361</pub-id></citation></ref>
<ref id="ref94"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Penn</surname> <given-names>A. C.</given-names></name> <name><surname>Zhang</surname> <given-names>C. L.</given-names></name> <name><surname>Georges</surname> <given-names>F.</given-names></name> <name><surname>Royer</surname> <given-names>L.</given-names></name> <name><surname>Breillat</surname> <given-names>C.</given-names></name> <name><surname>Hosy</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Hippocampal LTP and contextual learning require surface diffusion of AMPA receptors</article-title>. <source>Nature</source> <volume>549</volume>, <fpage>384</fpage>&#x2013;<lpage>388</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature23658</pub-id>, PMID: <pub-id pub-id-type="pmid">28902836</pub-id></citation></ref>
<ref id="ref95"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Piske</surname> <given-names>M.</given-names></name> <name><surname>Budd</surname> <given-names>M. A.</given-names></name> <name><surname>Qiu</surname> <given-names>A. Q.</given-names></name> <name><surname>Maan</surname> <given-names>E. J.</given-names></name> <name><surname>Sauve</surname> <given-names>L. J.</given-names></name> <name><surname>Forbes</surname> <given-names>J. C.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children</article-title>. <source>AIDS</source> <volume>32</volume>, <fpage>2583</fpage>&#x2013;<lpage>2592</lpage>. doi: <pub-id pub-id-type="doi">10.1097/QAD.0000000000001985</pub-id>, PMID: <pub-id pub-id-type="pmid">30134292</pub-id></citation></ref>
<ref id="ref96"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Powis</surname> <given-names>K. M.</given-names></name> <name><surname>Huo</surname> <given-names>Y.</given-names></name> <name><surname>Williams</surname> <given-names>P. L.</given-names></name> <name><surname>Kacanek</surname> <given-names>D.</given-names></name> <name><surname>Jao</surname> <given-names>J.</given-names></name> <name><surname>Patel</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Antiretroviral prescribing practices among pregnant women living with HIV in the United States, 2008-2017</article-title>. <source>JAMA Netw. Open</source> <volume>2</volume>:<fpage>e1917669</fpage>. doi: <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.17669</pub-id></citation></ref>
<ref id="ref97"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Powis</surname> <given-names>K. M.</given-names></name> <name><surname>Kitch</surname> <given-names>D.</given-names></name> <name><surname>Ogwu</surname> <given-names>A.</given-names></name> <name><surname>Hughes</surname> <given-names>M. D.</given-names></name> <name><surname>Lockman</surname> <given-names>S.</given-names></name> <name><surname>Leidner</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy</article-title>. <source>J. Infect. Dis.</source> <volume>204</volume>, <fpage>506</fpage>&#x2013;<lpage>514</lpage>. doi: <pub-id pub-id-type="doi">10.1093/infdis/jir307</pub-id>, PMID: <pub-id pub-id-type="pmid">21791651</pub-id></citation></ref>
<ref id="ref98"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>R&#x00E1;cz</surname> <given-names>A.</given-names></name> <name><surname>Ponomarenko</surname> <given-names>A. A.</given-names></name> <name><surname>Fuchs</surname> <given-names>E. C.</given-names></name> <name><surname>Monyer</surname> <given-names>H.</given-names></name></person-group> (<year>2009</year>). <article-title>Augmented hippocampal ripple oscillations in mice with reduced fast excitation onto Parvalbumin-positive cells</article-title>. <source>J. Neurosci.</source> <volume>29</volume>, <fpage>2563</fpage>&#x2013;<lpage>2568</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5036-08.2009</pub-id>, PMID: <pub-id pub-id-type="pmid">19244531</pub-id></citation></ref>
<ref id="ref99"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rencken</surname> <given-names>G.</given-names></name> <name><surname>Govender</surname> <given-names>P.</given-names></name> <name><surname>Uys</surname> <given-names>C. J. E.</given-names></name></person-group> (<year>2022</year>). <article-title>Neurobehavioural challenges experienced by HIV exposed infants: a study in South Africa</article-title>. <source>BMC Pediatr.</source> <volume>22</volume>, <fpage>479</fpage>&#x2013;<lpage>412</lpage>. doi: <pub-id pub-id-type="doi">10.1186/s12887-022-03526-5</pub-id>, PMID: <pub-id pub-id-type="pmid">35933329</pub-id></citation></ref>
<ref id="ref100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname> <given-names>M. L.</given-names></name> <name><surname>Russell</surname> <given-names>J. S.</given-names></name> <name><surname>Frederick</surname> <given-names>T.</given-names></name> <name><surname>Purswani</surname> <given-names>M.</given-names></name> <name><surname>Williams</surname> <given-names>P. L.</given-names></name> <name><surname>Siberry</surname> <given-names>G. K.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Risk for speech and language impairments in preschool age HIV-exposed uninfected children with in utero combination antiretroviral exposure</article-title>. <source>Pediatr. Infect. Dis. J.</source> <volume>37</volume>, <fpage>678</fpage>&#x2013;<lpage>685</lpage>. doi: <pub-id pub-id-type="doi">10.1097/INF.0000000000001875</pub-id>, PMID: <pub-id pub-id-type="pmid">29278615</pub-id></citation></ref>
<ref id="ref101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname> <given-names>M. L.</given-names></name> <name><surname>Zeldow</surname> <given-names>B.</given-names></name> <name><surname>Siberry</surname> <given-names>G. K.</given-names></name> <name><surname>Purswani</surname> <given-names>M.</given-names></name> <name><surname>Malee</surname> <given-names>K.</given-names></name> <name><surname>Hoffman</surname> <given-names>H. J.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants</article-title>. <source>Pediatr. Infect. Dis. J.</source> <volume>32</volume>, <fpage>e406</fpage>&#x2013;<lpage>e413</lpage>. doi: <pub-id pub-id-type="doi">10.1097/INF.0b013e31829b80ee</pub-id>, PMID: <pub-id pub-id-type="pmid">24067563</pub-id></citation></ref>
<ref id="ref102"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname> <given-names>K.</given-names></name> <name><surname>Liner</surname> <given-names>J.</given-names></name> <name><surname>Meeker</surname> <given-names>R. B.</given-names></name></person-group> (<year>2012</year>). <article-title>Antiretroviral neurotoxicity</article-title>. <source>J. Neuro-Oncol.</source> <volume>18</volume>, <fpage>388</fpage>&#x2013;<lpage>399</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s13365-012-0120-3</pub-id>, PMID: <pub-id pub-id-type="pmid">22811264</pub-id></citation></ref>
<ref id="ref103"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rudd</surname> <given-names>H.</given-names></name> <name><surname>Toborek</surname> <given-names>M.</given-names></name></person-group> (<year>2022</year>). <article-title>Pitfalls of antiretroviral therapy: Current status and long-term CNS toxicity</article-title>. <source>Biomol. Ther.</source> <volume>12</volume>:<fpage>894</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biom12070894</pub-id></citation></ref>
<ref id="ref104"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname> <given-names>A. B.</given-names></name> <name><surname>Kaul</surname> <given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Neuronal stress and injury caused by HIV-1, cART and drug abuse: Converging contributions to HAND</article-title>. <source>Brain Sci.</source> <volume>7</volume>:<fpage>25</fpage>. doi: <pub-id pub-id-type="doi">10.3390/brainsci7030025</pub-id></citation></ref>
<ref id="ref105"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanderson</surname> <given-names>D. J.</given-names></name> <name><surname>Bannerman</surname> <given-names>D. M.</given-names></name></person-group> (<year>2012</year>). <article-title>The role of habituation in hippocampus-dependent spatial working memory tasks: evidence from GluA1 AMPA receptor subunit knockout mice</article-title>. <source>Hippocampus</source> <volume>22</volume>, <fpage>981</fpage>&#x2013;<lpage>994</lpage>. doi: <pub-id pub-id-type="doi">10.1002/hipo.20896</pub-id>, PMID: <pub-id pub-id-type="pmid">21125585</pub-id></citation></ref>
<ref id="ref106"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanderson</surname> <given-names>D. J.</given-names></name> <name><surname>Good</surname> <given-names>M. A.</given-names></name> <name><surname>Seeburg</surname> <given-names>P. H.</given-names></name> <name><surname>Sprengel</surname> <given-names>R.</given-names></name> <name><surname>Rawlins</surname> <given-names>J. N. P.</given-names></name> <name><surname>Bannerman</surname> <given-names>D. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Chapter 9 the role of the GluR-A (GluR1) AMPA receptor subunit in learning and memory</article-title>. <source>Prog. Brain Res.</source> <volume>169</volume>, <fpage>159</fpage>&#x2013;<lpage>178</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0079-6123(07)00009-X</pub-id></citation></ref>
<ref id="ref107"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanmaneechai</surname> <given-names>O.</given-names></name> <name><surname>Puthanakit</surname> <given-names>T.</given-names></name> <name><surname>Louthrenoo</surname> <given-names>O.</given-names></name> <name><surname>Sirisanthana</surname> <given-names>V.</given-names></name></person-group> (<year>2005</year>). <article-title>Growth, developmental, and behavioral outcomes of HIV-affected preschool children in Thailand</article-title>. <source>J. Med. Assoc. Thail.</source> <volume>88</volume>, <fpage>1873</fpage>&#x2013;<lpage>1879</lpage>. PMID: <pub-id pub-id-type="pmid">16518988</pub-id></citation></ref>
<ref id="ref108"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarkar</surname> <given-names>A.</given-names></name> <name><surname>Balogun</surname> <given-names>K.</given-names></name> <name><surname>Guzman Lenis</surname> <given-names>M. S.</given-names></name> <name><surname>Acosta</surname> <given-names>S.</given-names></name> <name><surname>Mount</surname> <given-names>H. T.</given-names></name> <name><surname>Serghides</surname> <given-names>L.</given-names></name></person-group> (<year>2020</year>). <article-title>In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice</article-title>. <source>PLoS One</source> <volume>15</volume>:<fpage>e0242513</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0242513</pub-id>, PMID: <pub-id pub-id-type="pmid">33211746</pub-id></citation></ref>
<ref id="ref44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schnell</surname> <given-names>E.</given-names></name> <name><surname>Sizemore</surname> <given-names>M.</given-names></name> <name><surname>Karimzadegan</surname> <given-names>S.</given-names></name> <name><surname>Chen</surname> <given-names>L.</given-names></name> <name><surname>Bredt</surname> <given-names>D. S.</given-names></name></person-group> (<year>2002</year>). <article-title>Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number</article-title>. <source>Proc. Natl. Acad. Sci. USA</source> <volume>99</volume>, <fpage>13902</fpage>&#x2013;<lpage>13907</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.172511199</pub-id></citation></ref>
<ref id="ref109"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname> <given-names>A.</given-names></name> <name><surname>Gangwani</surname> <given-names>M. R.</given-names></name> <name><surname>Chaudhari</surname> <given-names>N. S.</given-names></name> <name><surname>Glazyrin</surname> <given-names>A.</given-names></name> <name><surname>Bhat</surname> <given-names>H. K.</given-names></name> <name><surname>Kumar</surname> <given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Neurotoxicity in the post-HAART era: Caution for the antiretroviral therapeutics</article-title>. <source>Neurotox. Res.</source> <volume>30</volume>, <fpage>677</fpage>&#x2013;<lpage>697</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12640-016-9646-0</pub-id></citation></ref>
<ref id="ref110"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shinar</surname> <given-names>S.</given-names></name> <name><surname>Agrawal</surname> <given-names>S.</given-names></name> <name><surname>Ryu</surname> <given-names>M.</given-names></name> <name><surname>Walmsley</surname> <given-names>S.</given-names></name> <name><surname>Serghides</surname> <given-names>L.</given-names></name> <name><surname>Yudin</surname> <given-names>M. H.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Perinatal outcomes in women living with HIV-1 and receiving antiretroviral therapy-a systematic review and meta-analysis</article-title>. <source>Acta Obstet. Gynecol. Scand.</source> <volume>101</volume>, <fpage>168</fpage>&#x2013;<lpage>182</lpage>. doi: <pub-id pub-id-type="doi">10.1111/aogs.14282</pub-id>, PMID: <pub-id pub-id-type="pmid">34704251</pub-id></citation></ref>
<ref id="ref111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sirois</surname> <given-names>P. A.</given-names></name> <name><surname>Chernoff</surname> <given-names>M. C.</given-names></name> <name><surname>Malee</surname> <given-names>K. M.</given-names></name> <name><surname>Garvie</surname> <given-names>P. A.</given-names></name> <name><surname>Harris</surname> <given-names>L. L.</given-names></name> <name><surname>Williams</surname> <given-names>P. L.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Associations of memory and executive functioning with academic and adaptive functioning among youth with perinatal HIV exposure and/or infection</article-title>. <source>J Pediatric Infect Dis Soc.</source> <volume>5</volume>, <fpage>S24</fpage>&#x2013;<lpage>S32</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jpids/piw046</pub-id>, PMID: <pub-id pub-id-type="pmid">27856673</pub-id></citation></ref>
<ref id="ref112"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sirois</surname> <given-names>P. A.</given-names></name> <name><surname>Huo</surname> <given-names>Y.</given-names></name> <name><surname>Williams</surname> <given-names>P. L.</given-names></name> <name><surname>Malee</surname> <given-names>K.</given-names></name> <name><surname>Garvie</surname> <given-names>P. A.</given-names></name> <name><surname>Kammerer</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants</article-title>. <source>Pediatr. Infect. Dis. J.</source> <volume>32</volume>, <fpage>648</fpage>&#x2013;<lpage>655</lpage>. doi: <pub-id pub-id-type="doi">10.1097/INF.0b013e318284129a</pub-id>, PMID: <pub-id pub-id-type="pmid">23340561</pub-id></citation></ref>
<ref id="ref113"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Slogrove</surname> <given-names>A. L.</given-names></name> <name><surname>Powis</surname> <given-names>K. M.</given-names></name> <name><surname>Johnson</surname> <given-names>L. F.</given-names></name> <name><surname>Stover</surname> <given-names>J.</given-names></name> <name><surname>Mahy</surname> <given-names>M.</given-names></name></person-group> (<year>2020</year>). <article-title>Global estimates of children HIV exposed and uninfected in the evolving HIV epidemic: 2000 to 2018</article-title>. <source>Lancet Glob. Health</source> <volume>8</volume>:<fpage>e67</fpage>. doi: <pub-id pub-id-type="doi">10.1016/S2214-109X(19)30448-6</pub-id></citation></ref>
<ref id="ref114"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spencer Noakes</surname> <given-names>T. L.</given-names></name> <name><surname>Henkelman</surname> <given-names>R. M.</given-names></name> <name><surname>Nieman</surname> <given-names>B. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Partitioning k-space for cylindrical three-dimensional rapid acquisition with relaxation enhancement imaging in the mouse brain</article-title>. <source>NMR Biomed.</source> <volume>30</volume>:<fpage>e3802</fpage>. doi: <pub-id pub-id-type="doi">10.1002/nbm.3802</pub-id>, PMID: <pub-id pub-id-type="pmid">28902423</pub-id></citation></ref>
<ref id="ref115"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Springer</surname> <given-names>P. E.</given-names></name> <name><surname>Slogrove</surname> <given-names>A. L.</given-names></name> <name><surname>Kidd</surname> <given-names>M.</given-names></name> <name><surname>Kalk</surname> <given-names>E.</given-names></name> <name><surname>Bettinger</surname> <given-names>J. A.</given-names></name> <name><surname>Esser</surname> <given-names>M. M.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Neurodevelopmental and behavioural outcomes of HIV-exposed uninfected and HIV-unexposed children at 2&#x2013;3 years of age in Cape Town, South Africa</article-title>. <source>AIDS Care-Psycholog. Socio-Med. Aspects of AIDS/HIV.</source> <volume>32</volume>, <fpage>411</fpage>&#x2013;<lpage>419</lpage>. doi: <pub-id pub-id-type="doi">10.1080/09540121.2019.1637506</pub-id></citation></ref>
<ref id="ref116"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steadman</surname> <given-names>P. E.</given-names></name> <name><surname>Ellegood</surname> <given-names>J.</given-names></name> <name><surname>Szulc</surname> <given-names>K. U.</given-names></name> <name><surname>Turnbull</surname> <given-names>D. H.</given-names></name> <name><surname>Joyner</surname> <given-names>A. L.</given-names></name> <name><surname>Henkelman</surname> <given-names>R. M.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Genetic effects on cerebellar structure across mouse models of autism using a magnetic resonance imaging atlas</article-title>. <source>Autism Res.</source> <volume>7</volume>, <fpage>124</fpage>&#x2013;<lpage>137</lpage>. doi: <pub-id pub-id-type="doi">10.1002/aur.1344</pub-id>, PMID: <pub-id pub-id-type="pmid">24151012</pub-id></citation></ref>
<ref id="ref117"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>S&#x00FC;dhof</surname> <given-names>T. C.</given-names></name> <name><surname>Malenka</surname> <given-names>R. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Understanding synapses: past, present, and future</article-title>. <source>Neuron</source> <volume>60</volume>, <fpage>469</fpage>&#x2013;<lpage>476</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2008.10.011</pub-id>, PMID: <pub-id pub-id-type="pmid">18995821</pub-id></citation></ref>
<ref id="ref118"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname> <given-names>S. M.</given-names></name> <name><surname>Berkowitz</surname> <given-names>L. E.</given-names></name> <name><surname>Clark</surname> <given-names>B. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Behavioral and neural subsystems of rodent exploration</article-title>. <source>Learn. Motiv.</source> <volume>61</volume>, <fpage>3</fpage>&#x2013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.lmot.2017.03.009</pub-id>, PMID: <pub-id pub-id-type="pmid">30270939</pub-id></citation></ref>
<ref id="ref119"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Toledo</surname> <given-names>G.</given-names></name> <name><surname>C&#x00F4;t&#x00E9;</surname> <given-names>H. C. F.</given-names></name> <name><surname>Adler</surname> <given-names>C.</given-names></name> <name><surname>Thorne</surname> <given-names>C.</given-names></name> <name><surname>Goetghebuer</surname> <given-names>T.</given-names></name></person-group> (<year>2021</year>). <article-title>Neurological development of children who are HIV-exposed and uninfected</article-title>. <source>Dev. Med. Child Neurol.</source> <volume>63</volume>, <fpage>1161</fpage>&#x2013;<lpage>1170</lpage>. doi: <pub-id pub-id-type="doi">10.1111/dmcn.14921</pub-id></citation></ref>
<ref id="ref120"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ullmann</surname> <given-names>J. F. P.</given-names></name> <name><surname>Watson</surname> <given-names>C.</given-names></name> <name><surname>Janke</surname> <given-names>A. L.</given-names></name> <name><surname>Kurniawan</surname> <given-names>N. D.</given-names></name> <name><surname>Reutens</surname> <given-names>D. C.</given-names></name></person-group> (<year>2013</year>). <article-title>A segmentation protocol and MRI atlas of the C57BL/6J mouse neocortex</article-title>. <source>NeuroImage</source> <volume>78</volume>, <fpage>196</fpage>&#x2013;<lpage>203</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroimage.2013.04.008</pub-id>, PMID: <pub-id pub-id-type="pmid">23587687</pub-id></citation></ref>
<ref id="ref121"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Praag</surname> <given-names>H.</given-names></name> <name><surname>Dreyfus</surname> <given-names>C. F.</given-names></name> <name><surname>Black</surname> <given-names>I. B.</given-names></name></person-group> (<year>1994</year>). <article-title>Dissociation of motor hyperactivity and spatial memory deficits by selective hippocampal lesions in the neonatal rat</article-title>. <source>J. Cogn. Neurosci.</source> <volume>6</volume>, <fpage>321</fpage>&#x2013;<lpage>331</lpage>. doi: <pub-id pub-id-type="doi">10.1162/jocn.1994.6.4.321</pub-id>, PMID: <pub-id pub-id-type="pmid">23961728</pub-id></citation></ref>
<ref id="ref122"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Rie</surname> <given-names>A.</given-names></name> <name><surname>Mupuala</surname> <given-names>A.</given-names></name> <name><surname>Dow</surname> <given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo</article-title>. <source>Pediatrics</source> <volume>122</volume>:<fpage>e123</fpage>. doi: <pub-id pub-id-type="doi">10.1542/peds.2007-2558</pub-id></citation></ref>
<ref id="ref123"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Venerosi</surname> <given-names>A.</given-names></name> <name><surname>Cirulli</surname> <given-names>F.</given-names></name> <name><surname>Capone</surname> <given-names>F.</given-names></name> <name><surname>Alleva</surname> <given-names>E.</given-names></name></person-group> (<year>2003</year>). <article-title>Prolonged perinatal AZT administration and early maternal separation: effects on social and emotional behaviour of periadolescent mice</article-title>. <source>Pharmacol. Biochem. Behav.</source> <volume>74</volume>, <fpage>671</fpage>&#x2013;<lpage>681</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0091-3057(02)01068-7</pub-id>, PMID: <pub-id pub-id-type="pmid">12543234</pub-id></citation></ref>
<ref id="ref124"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Venerosi</surname> <given-names>A.</given-names></name> <name><surname>Valanzano</surname> <given-names>A.</given-names></name> <name><surname>Alleva</surname> <given-names>E.</given-names></name> <name><surname>Calamandrei</surname> <given-names>G.</given-names></name></person-group> (<year>2001</year>). <article-title>Prenatal exposure to anti-HIV drugs: neurobehavioral effects of zidovudine (AZT) lamivudine (3TC)</article-title>. <source>Treatment in Mice.</source> <volume>63</volume>, <fpage>26</fpage>&#x2013;<lpage>37</lpage>. doi: <pub-id pub-id-type="doi">10.1002/1096-9926(200101)63:1&#x003C;26::AID-TERA1005&#x003E;3.0.CO;2-G</pub-id></citation></ref>
<ref id="ref125"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Voitov</surname> <given-names>I.</given-names></name> <name><surname>Mrsic-Flogel</surname> <given-names>T. D.</given-names></name></person-group> (<year>2022</year>). <article-title>Cortical feedback loops bind distributed representations of working memory</article-title>. <source>Nature</source> <volume>608</volume>, <fpage>381</fpage>&#x2013;<lpage>389</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41586-022-05014-3</pub-id>, PMID: <pub-id pub-id-type="pmid">35896749</pub-id></citation></ref>
<ref id="ref126"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X. J.</given-names></name></person-group> (<year>1999</year>). <article-title>Synaptic basis of Cortical persistent activity: the importance of NMDA receptors to working memory</article-title>. <source>J. Neurosci.</source> <volume>19</volume>, <fpage>9587</fpage>&#x2013;<lpage>9603</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-21-09587.1999</pub-id>, PMID: <pub-id pub-id-type="pmid">10531461</pub-id></citation></ref>
<ref id="ref127"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wedderburn</surname> <given-names>C. J.</given-names></name> <name><surname>Evans</surname> <given-names>C.</given-names></name> <name><surname>Yeung</surname> <given-names>S.</given-names></name> <name><surname>Gibb</surname> <given-names>D. M.</given-names></name> <name><surname>Donald</surname> <given-names>K. A.</given-names></name> <name><surname>Prendergast</surname> <given-names>A. J.</given-names></name></person-group> (<year>2019a</year>). <article-title>Growth and neurodevelopment of HIV-exposed uninfected children: a conceptual framework</article-title>. <source>Curr. HIV/AIDS Rep.</source> <volume>16</volume>, <fpage>501</fpage>&#x2013;<lpage>513</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11904-019-00459-0</pub-id>, PMID: <pub-id pub-id-type="pmid">31732866</pub-id></citation></ref>
<ref id="ref128"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wedderburn</surname> <given-names>C. J.</given-names></name> <name><surname>Groenewold</surname> <given-names>N. A.</given-names></name> <name><surname>Roos</surname> <given-names>A.</given-names></name> <name><surname>Yeung</surname> <given-names>S.</given-names></name> <name><surname>Fouche</surname> <given-names>J. P.</given-names></name> <name><surname>Rehman</surname> <given-names>A. M.</given-names></name> <etal/></person-group>. (<year>2022a</year>). <article-title>Early structural brain development in infants exposed to HIV and antiretroviral therapy in utero in a south African birth cohort</article-title>. <source>J. Int. AIDS Soc.</source> <volume>25</volume>:<fpage>e25863</fpage>. doi: <pub-id pub-id-type="doi">10.1002/jia2.25863</pub-id>, PMID: <pub-id pub-id-type="pmid">35041774</pub-id></citation></ref>
<ref id="ref129"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wedderburn</surname> <given-names>C. J.</given-names></name> <name><surname>Weldon</surname> <given-names>E.</given-names></name> <name><surname>Bertran-Cobo</surname> <given-names>C.</given-names></name> <name><surname>Rehman</surname> <given-names>A. M.</given-names></name> <name><surname>Stein</surname> <given-names>D. J.</given-names></name> <name><surname>Gibb</surname> <given-names>D. M.</given-names></name> <etal/></person-group>. (<year>2022b</year>). <article-title>Early neurodevelopment of HIV-exposed uninfected children in the era of antiretroviral therapy: a systematic review and meta-analysis</article-title>. <source>Lancet Child Adolesc Health.</source> <volume>6</volume>, <fpage>393</fpage>&#x2013;<lpage>408</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2352-4642(22)00071-2</pub-id></citation></ref>
<ref id="ref130"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wedderburn</surname> <given-names>C. J.</given-names></name> <name><surname>Yeung</surname> <given-names>S.</given-names></name> <name><surname>Rehman</surname> <given-names>A. M.</given-names></name> <name><surname>Stadler</surname> <given-names>J. A. M.</given-names></name> <name><surname>Nhapi</surname> <given-names>R. T.</given-names></name> <name><surname>Barnett</surname> <given-names>W.</given-names></name> <etal/></person-group>. (<year>2019b</year>). <article-title>Neurodevelopment of HIV-exposed uninfected children in South Africa: outcomes from an observational birth cohort study</article-title>. <source>Lancet Child Adolesc Health.</source> <volume>3</volume>, <fpage>803</fpage>&#x2013;<lpage>813</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2352-4642(19)30250-0</pub-id>, PMID: <pub-id pub-id-type="pmid">31515160</pub-id></citation></ref>
<ref id="ref131"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname> <given-names>P. L.</given-names></name> <name><surname>Hazra</surname> <given-names>R.</given-names></name> <name><surname>Van Dyke</surname> <given-names>R. B.</given-names></name> <name><surname>Yildirim</surname> <given-names>C.</given-names></name> <name><surname>Crain</surname> <given-names>M. J.</given-names></name> <name><surname>Seage</surname> <given-names>G. R.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design</article-title>. <source>AIDS</source> <volume>30</volume>, <fpage>133</fpage>&#x2013;<lpage>144</lpage>. doi: <pub-id pub-id-type="doi">10.1097/QAD.0000000000000916</pub-id>, PMID: <pub-id pub-id-type="pmid">26731758</pub-id></citation></ref>
<ref id="ref132"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname> <given-names>K.</given-names></name> <name><surname>Nabeshima</surname> <given-names>T.</given-names></name></person-group> (<year>2004</year>). <article-title>Interaction of BDNF/TrkB signaling with NMDA receptor in learning and memory</article-title>. <source>Drug News Perspect.</source> <volume>17</volume>, <fpage>435</fpage>&#x2013;<lpage>438</lpage>. doi: <pub-id pub-id-type="doi">10.1358/dnp.2004.17.7.863702</pub-id>, PMID: <pub-id pub-id-type="pmid">15514702</pub-id></citation></ref>
<ref id="ref133"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname> <given-names>T. J.</given-names></name> <name><surname>Malee</surname> <given-names>K.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Smith</surname> <given-names>R.</given-names></name> <name><surname>Redmond</surname> <given-names>S.</given-names></name> <name><surname>Rice</surname> <given-names>M. L.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>In utero antiretroviral exposure and risk of neurodevelopmental problems in HIV-exposed uninfected 5-year-old children</article-title>. <source>AIDS Patient Care STDs</source> <volume>37</volume>, <fpage>119</fpage>&#x2013;<lpage>130</lpage>. doi: <pub-id pub-id-type="doi">10.1089/apc.2022.0189</pub-id>, PMID: <pub-id pub-id-type="pmid">36827595</pub-id></citation></ref>
<ref id="ref134"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Young</surname> <given-names>J. M.</given-names></name> <name><surname>Bitnun</surname> <given-names>A.</given-names></name> <name><surname>Read</surname> <given-names>S. E.</given-names></name> <name><surname>Lou</surname> <given-names>S. M.</given-names></name></person-group> (<year>2021</year>). <article-title>Early academic achievement of HIV-exposed uninfected children compared to HIV-unexposed uninfected children at 5 years of age</article-title>. <source>Child Neuropsychol.</source> <volume>27</volume>, <fpage>532</fpage>&#x2013;<lpage>547</lpage>. doi: <pub-id pub-id-type="doi">10.1080/09297049.2021.1871891</pub-id>, PMID: <pub-id pub-id-type="pmid">33461418</pub-id></citation></ref>
</ref-list>
</back>
</article>